<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5021280</article-id><article-id pub-id-type="pmid">27622494</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1006307</article-id><article-id pub-id-type="publisher-id">PGENETICS-D-16-01074</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene Expression</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological Tissue</subject><subj-group><subject>Connective Tissue</subject><subj-group><subject>Cartilage</subject><subj-group><subject>Chondrocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological Tissue</subject><subj-group><subject>Connective Tissue</subject><subj-group><subject>Cartilage</subject><subj-group><subject>Chondrocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Connective Tissue Cells</subject><subj-group><subject>Chondrocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological Tissue</subject><subj-group><subject>Connective Tissue</subject><subj-group><subject>Connective Tissue Cells</subject><subj-group><subject>Chondrocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological Tissue</subject><subj-group><subject>Connective Tissue</subject><subj-group><subject>Connective Tissue Cells</subject><subj-group><subject>Chondrocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Bone</subject><subj-group><subject>Growth Plate</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Bone</subject><subj-group><subject>Growth Plate</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological Tissue</subject><subj-group><subject>Connective Tissue</subject><subj-group><subject>Bone</subject><subj-group><subject>Growth Plate</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological Tissue</subject><subj-group><subject>Connective Tissue</subject><subj-group><subject>Bone</subject><subj-group><subject>Growth Plate</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Phenotypes</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Mutation</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Developmental Biology</subject><subj-group><subject>Twins</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Mutation</subject><subj-group><subject>Frameshift Mutation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Sequencing Techniques</subject><subj-group><subject>Sequence Analysis</subject><subj-group><subject>Sequence Motif Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Sequencing Techniques</subject><subj-group><subject>Sequence Analysis</subject><subj-group><subject>Sequence Motif Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Altered mRNA Splicing, Chondrocyte Gene Expression and Abnormal Skeletal Development due to <italic>SF3B4</italic> Mutations in Rodriguez Acrofacial Dysostosis</article-title><alt-title alt-title-type="running-head"><italic>SF3B4</italic> Mutations in Rodriguez Acrofacial Dysostosis</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Marques</surname><given-names>Felipe</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Tenney</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6097-0402</contrib-id><name><surname>Duran</surname><given-names>Ivan</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6312-7637</contrib-id><name><surname>Martin</surname><given-names>Jorge</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nevarez</surname><given-names>Lisette</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pogue</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Krakow</surname><given-names>Deborah</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="aff" rid="aff007"><sup>7</sup></xref><xref ref-type="aff" rid="aff008"><sup>8</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Cohn</surname><given-names>Daniel H.</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3683-8414</contrib-id><name><surname>Li</surname><given-names>Bing</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias Gen&#x000f4;micas e Biotecnologia, Universidade Cat&#x000f3;lica de Bras&#x000ed;lia, Bras&#x000ed;lia, Brazil</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Laborat&#x000f3;rio de Biotecnologia, Universidade CEUMA, Campus Renascen&#x000e7;a, S&#x000e3;o Lu&#x000ed;s-MA, Brazil</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America</addr-line></aff><aff id="aff004"><label>4</label><addr-line>Department of Pediatrics, Division of Genetics, University of California Los Angeles, Los Angeles, California, United States of America</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Department of Orthopaedic Surgery, University of California Los Angeles, Los Angeles, California, United States of America</addr-line></aff><aff id="aff006"><label>6</label><addr-line>Department of Molecular, Cell, and Developmental Biology, University of California Los Angeles, Los Angeles, California, United States of America</addr-line></aff><aff id="aff007"><label>7</label><addr-line>Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California, United States of America</addr-line></aff><aff id="aff008"><label>8</label><addr-line>Department of Human Genetics, University of California Los Angeles, Los Angeles, California, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Bateman</surname><given-names>John F</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Murdoch Childrens Research Institute, AUSTRALIA</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> FM JT ID RP DK DHC BL.</p></list-item><list-item><p><bold>Data curation:</bold> FM JT ID JM LN DK DHC BL.</p></list-item><list-item><p><bold>Formal analysis:</bold> FM ID LN DK DHC BL.</p></list-item><list-item><p><bold>Funding acquisition:</bold> RP DHC BL.</p></list-item><list-item><p><bold>Investigation:</bold> FM JT ID JM LN DK DHC BL.</p></list-item><list-item><p><bold>Methodology:</bold> FM ID JM LN DK DHC BL.</p></list-item><list-item><p><bold>Project administration:</bold> DK DHC BL.</p></list-item><list-item><p><bold>Resources:</bold> JT DK DHC BL.</p></list-item><list-item><p><bold>Software:</bold> BL.</p></list-item><list-item><p><bold>Supervision:</bold> RP DK DHC BL.</p></list-item><list-item><p><bold>Validation:</bold> FM ID JM LN BL.</p></list-item><list-item><p><bold>Visualization:</bold> FM JT ID JM DK DHC BL.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> FM JT BL.</p></list-item><list-item><p><bold>Writing &#x02013; review &#x00026; editing:</bold> FM JT ID JM LN RP DK DHC BL.</p></list-item></list></p></fn><corresp id="cor001">* E-mail: <email>dkrakow@mednet.ucla.edu</email> (DK); <email>dcohn@mcdb.ucla.edu</email> (DHC)</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>9</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2016</year></pub-date><pub-date pub-type="ecorrected"><day>18</day><month>11</month><year>2016</year></pub-date><volume>12</volume><issue>9</issue><elocation-id>e1006307</elocation-id><history><date date-type="received"><day>13</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>17</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Marques et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Marques et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pgen.1006307.pdf"/><abstract><p>The acrofacial dysostoses (AFD) are a genetically heterogeneous group of inherited disorders with craniofacial and limb abnormalities. Rodriguez syndrome is a severe, usually perinatal lethal AFD, characterized by severe retrognathia, oligodactyly and lower limb abnormalities. Rodriguez syndrome has been proposed to be a severe form of Nager syndrome, a non-lethal AFD that results from mutations in <italic>SF3B4</italic>, a component of the U2 small nuclear ribonucleoprotein particle (U2 snRNP). Furthermore, a case with a phenotype intermediate between Rodriguez and Nager syndromes has been shown to have an <italic>SF3B4</italic> mutation. We identified heterozygosity for <italic>SF3B4</italic> mutations in Rodriguez syndrome, confirming that the phenotype is a dominant disorder that is allelic with Nager syndrome. The mutations led to reduced SF3B4 synthesis and defects in mRNA splicing, primarily exon skipping. The mutations also led to reduced expression in growth plate chondrocytes of target genes, including the <italic>DLX5</italic>, <italic>DLX6</italic>, <italic>SOX9</italic>, and <italic>SOX6</italic> transcription factor genes, which are known to be important for skeletal development. These data provide mechanistic insight toward understanding how <italic>SF3B4</italic> mutations lead to the skeletal abnormalities observed in the acrofacial dysostoses.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>The acrofacial dysostoses (AFD) are inherited disorders with abnormalities of the facial and limb bones. Rodriguez syndrome is a severe type of AFD that is usually lethal in the immediate perinatal period. Rodriguez syndrome has been proposed to be a severe form of Nager syndrome, a non-lethal AFD that results from mutations in <italic>SF3B4</italic>, a component of mRNA splicing machinery needed for proper maturation of primary transcripts. Furthermore, a case with a phenotype intermediate between Rodriguez and Nager syndromes has been shown to have an <italic>SF3B4</italic> mutation. We found that mutations in <italic>SF3B4</italic> produce Rodriguez syndrome, further demonstrating that it is allelic with Nager syndrome. The consequences of the mutations include abnormal splicing and reduced expression in growth plate chondrocytes of genes that are important for proper development of the skeleton, providing mechanistic insight toward understanding how <italic>SF3B4</italic> mutations lead to the skeletal abnormalities observed in the acrofacial dysostoses.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution></institution-wrap></funding-source><award-id>R01AR062651</award-id><principal-award-recipient><name><surname>Cohn</surname><given-names>Dan H</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution></institution-wrap></funding-source><award-id>RO1AR066124</award-id><principal-award-recipient><name><surname>Krakow</surname><given-names>Deborah</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000912</institution-id><institution>March of Dimes Foundation</institution></institution-wrap></funding-source><award-id>none</award-id><principal-award-recipient><name><surname>Cohn</surname><given-names>Dan H</given-names></name></principal-award-recipient></award-group><award-group id="award004"><funding-source><institution>Joseph Drown Foundation</institution></funding-source><award-id>none</award-id><principal-award-recipient><name><surname>Krakow</surname><given-names>Deborah</given-names></name></principal-award-recipient></award-group><award-group id="award005"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>5T32GM008243</award-id><principal-award-recipient><name><surname>Tenney</surname><given-names>Jessica</given-names></name></principal-award-recipient></award-group><award-group id="award006"><funding-source><institution>CAPES</institution></funding-source><award-id>PVE-A120/2013</award-id><principal-award-recipient><name><surname>Pogue</surname><given-names>Robert</given-names></name></principal-award-recipient></award-group><award-group id="award007"><funding-source><institution>CAPES</institution></funding-source><award-id>564537/2010</award-id><principal-award-recipient><name><surname>Pogue</surname><given-names>Robert</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported in part by grants from the National Institutes of Health (NIAMS grants R01 AR062651 and RO1 AR066124). We also thank the March of Dimes and the Joseph Drown Foundation for their support of the International Skeletal Dysplasia Registry. JT was supported by the National Institutes of Health UCLA Intercampus Medical Genetics Training Grant 5T32 GM008243. FM, RP and DHC were supported in part by a grant from the Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES, Brazil; grant number PVE-A120/2013). FM and RP were also supported by the Rede Pro-Centro-Oeste through the Brazilian Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq), CAPES, and Funda&#x000e7;&#x000e3;o de Apoio a Pesquisa do Distrito Federal (FAP-DF) (project number 564537/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="2"/><page-count count="21"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>The acrofacial dysostoses (AFD) are a genetically heterogeneous group of inherited disorders unified by craniofacial and limb abnormalities. At least 18 types of AFD have been characterized and, depending on the specific patterns of limb abnormalities, they have been further classified into those with preaxial limb abnormalities, those with postaxial defects and those which cannot be classified into the first two groups [<xref rid="pgen.1006307.ref001" ref-type="bibr">1</xref>]. Miller syndrome (OMIM 263750) is a recessively inherited AFD, which results from pyrimidine biosynthesis defects due to mutations in <italic>DHODH</italic> [<xref rid="pgen.1006307.ref002" ref-type="bibr">2</xref>]. Weyers AFD (OMIM 193530) is dominantly inherited phenotype caused by mutations in either <italic>EVC</italic>1 or <italic>EVC2</italic>, leading to defective cilia-mediated hedgehog signaling [<xref rid="pgen.1006307.ref003" ref-type="bibr">3</xref>,<xref rid="pgen.1006307.ref004" ref-type="bibr">4</xref>]. Dominant mutations affecting the RNA polymerase subunit POLR1A and ribosomal biogenesis have been found in AFD, Cincinnati type (OMIM 616462) [<xref rid="pgen.1006307.ref005" ref-type="bibr">5</xref>]. Related mandibulofacial dysostosis phenotypes, including Treacher-Collins syndrome, can also result from defects in ribosomal biogenesis [<xref rid="pgen.1006307.ref006" ref-type="bibr">6</xref>]. <italic>EFTUD2</italic> encodes a GTPase which is a component of the U5 snRNP. Identification of <italic>EFTUD2</italic> mutations in mandibulofacial dysostosis of the Guion-Almeida type (OMIM 610536) demonstrated that pre-mRNA splicing abnormalities could produce an AFD [<xref rid="pgen.1006307.ref007" ref-type="bibr">7</xref>]. Also demonstrating a link with pre-mRNA splicing, mutations in <italic>EIF4A3</italic> which affect the activity of the exon junction complex have been characterized in Richieri-Costa-Pereira syndrome (OMIM 268305) [<xref rid="pgen.1006307.ref008" ref-type="bibr">8</xref>]. Similarly, mutations in the gene encoding the SF3B4 protein (also known as SAP49), a component of the U2 snRNP, have been found to produce Nager syndrome (OMIM 154400) [<xref rid="pgen.1006307.ref009" ref-type="bibr">9</xref>&#x02013;<xref rid="pgen.1006307.ref012" ref-type="bibr">12</xref>]. While the genes involved in the characterized AFDs demonstrate that defects in a variety of basic biochemical processes can lead to these phenotypes, the underlying reasons for the distinct distribution of abnormalities in the craniofacies and distal limbs are not well understood.</p><p>Rodriguez syndrome (OMIM 201170) is a severe, usually perinatal lethal AFD characterized by severe retrognathia, hypertelorism with deep set eyes and deficient supra-orbital ridges, low set and posteriorly rotated ears, and oligodactyly with additional preaxial or postaxial abnormalities. Lower limb abnormalities, including fibular hypoplasia and equinovarus, are common and the spine, ribs and pelvis can also be involved. The initial description of the phenotype was a sibship of three affected offspring, suggesting recessive inheritance, but the seven cases reported subsequently were all sporadic in their families and did not recur, a pattern more consistent with <italic>de novo</italic> dominant mutations [<xref rid="pgen.1006307.ref013" ref-type="bibr">13</xref>&#x02013;<xref rid="pgen.1006307.ref019" ref-type="bibr">19</xref>].</p><p>Recently, McPherson <italic>et al</italic>. described a case of a surviving child with a phenotype intermediate between Rodriguez syndrome and the non-lethal Nager syndrome form of AFD [<xref rid="pgen.1006307.ref014" ref-type="bibr">14</xref>]. The child was heterozygous for a mutation in <italic>SF3B4</italic>, supporting dominant mutations as underlying the phenotype and raising the possibility that these two AFDs are allelic. To test this hypothesis, we determined the sequence of <italic>SF3B4</italic> in one case of classic Rodriguez syndrome and in a set of monozygotic twins with an intermediate phenotype, identifying heterozygosity for <italic>SF3B4</italic> mutations in both families. At the biochemical level, the mutations led to reduced SF3B4 synthesis. Cartilage RNA-seq analysis identified reduced expression and/or altered splicing of target genes, including transcription factors known to be important in skeletal development, consistent with differential effects on pre-mRNA splicing and gene expression as underlying mechanisms of disease.</p></sec><sec sec-type="results" id="sec002"><title>Results</title><sec id="sec003"><title>Clinical findings</title><sec id="sec004"><title>Family R14-123</title><p>The proband, International Skeletal Dysplasia Registry (ISDR) reference number R14-123A, was born to an unaffected 26-year-old G<sub>1</sub>P<sub>0</sub> mother and 32-year-old unaffected father. Prenatal ultrasound at 29 weeks gestation indicated that the fetus was small for gestational age and had microcephaly, severe retrognathia, severely shortened and malformed appendicular bones, oligodactyly with prexial polydactyly, coarctation of the aorta and polyhydramnios (<xref ref-type="supplementary-material" rid="pgen.1006307.s001">S1 Fig</xref> and <xref ref-type="table" rid="pgen.1006307.t001">Table 1</xref>), consistent with Rodriguez syndrome, a severe acrofacial dysostosis. Preterm labor and delivery ensued at 30 weeks gestation and the newborn survived for one hour. Postnatal findings showed multiple craniofacial and distal limb abnormalities including hypertelorism, bilateral microtia, severe micrognathia, severe rhizomelia, mesomelia and oligodactyly with duplication of the thumb. Radiographs demonstrated handlebar clavicles, small scapulae, hypoplastic humeri, humeroradial synostosis, absent pubis bone, malformed radii, absent ulnae, absent fibulae and oligodactyly with preaxial polydactyly on one hand, and oligodactyly on the other hand (<xref ref-type="fig" rid="pgen.1006307.g001">Fig 1</xref> and <xref ref-type="table" rid="pgen.1006307.t001">Table 1</xref>). The clinical findings are summarized in <xref ref-type="table" rid="pgen.1006307.t001">Table 1</xref>, and, along with the perinatal lethality, supported a diagnosis of Rodriguez syndrome.</p><fig id="pgen.1006307.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1006307.g001</object-id><label>Fig 1</label><caption><title>Radiographic phenotypes of cases R14-123A and R08-269A &#x00026; B.</title><p>(A) A/P radiograph of the chest of R14-123<sup>a</sup> showing small scapulae, 11 ribs, and abnormally formed hypoplastic humeri with radioulnar synostosis. (B) Hand radiograph showing oligodactyly, hypoplastic carpal bones and preaxial polydactyly. (C) Bilateral lower extremities showing hypoplastic or absent fibulae with small stippled calcanei. (D) A/P radiograph of R08-269A showing hypoplastic radii, oligodactyly, absent thumbs, thin fibulae, and club foot. (E) A/P radiograph of R08-269B showing 11 ribs, absent radii and ulnae.</p></caption><graphic xlink:href="pgen.1006307.g001"/></fig><table-wrap id="pgen.1006307.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1006307.t001</object-id><label>Table 1</label><caption><title>Summary of the ultrasound, clinical and radiographic findings.</title></caption><alternatives><graphic id="pgen.1006307.t001g" xlink:href="pgen.1006307.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Case Number</th><th align="left" rowspan="1" colspan="1">R08-269A</th><th align="left" rowspan="1" colspan="1">R08-269B</th><th align="left" rowspan="1" colspan="1">R14-123</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><bold>Gestational age at delivery</bold></td><td align="left" rowspan="1" colspan="1">Pregnancy interrupted at 22 weeks</td><td align="left" rowspan="1" colspan="1">Pregnancy interrupted at 22 weeks</td><td align="left" rowspan="1" colspan="1">Preterm labor and delivery at 30 weeks. Died one hour after delivery</td></tr><tr><td align="left" rowspan="3" colspan="1"><bold>Prenatal Ultrasound</bold></td><td align="left" rowspan="1" colspan="1">Craniofacial: microcephaly, micrognathia,</td><td align="left" rowspan="1" colspan="1">Craniofacial: microcephaly, micrognathia</td><td align="left" rowspan="1" colspan="1">Craniofacial: low-set deficient ears and severe retrognathia</td></tr><tr><td align="left" rowspan="1" colspan="1">Extremities: shortened humeri, radii, ulnae</td><td align="left" rowspan="1" colspan="1">Extremities: shortened humeri, radii, ulnae</td><td align="left" rowspan="1" colspan="1">Extremities: severe rhizomelia of humeri, absent radii and ulnae, oligodactyly with preaxial duplication of the thumbs, femoral rhizomelia, absent fibulae, clubfeet with right oligodactyly</td></tr><tr><td align="left" rowspan="1" colspan="1">Other: placenta&#x02013;monochorionic/diamniotic size discordance (twin A &#x0003e; twin B)</td><td align="left" rowspan="1" colspan="1">Other: placenta -monochorionic/diamniotic, size discordance (twin A &#x0003e; twin B)</td><td align="left" rowspan="1" colspan="1">Other: polyhydramnios, coarctation of the aorta</td></tr><tr><td align="center" rowspan="3" colspan="1"><bold>Postmortem Examination</bold></td><td align="left" rowspan="1" colspan="1">Craniofacial: hypertelorism, low-set ears and severe microtia, prominent nasal bridge, long phitrum, thin upper lip, malar hypoplasia with severe micrognathia</td><td align="left" rowspan="1" colspan="1">Craniofacial: hypertelorism, microtia, prominent nasal bridge, malar hypoplasia with severe micrognathia</td><td align="left" rowspan="1" colspan="1">Craniofacial: hypertelorism, low-set ears, microtia, broad nasal bridge, macrostomia</td></tr><tr><td align="left" rowspan="2" colspan="1">Extremities: left equinovarus</td><td align="left" rowspan="2" colspan="1">Extremities: right equinovarus</td><td align="left" rowspan="1" colspan="1">Extremities: severe rhizomelia, oligodactyly of the hands with preaxial duplication of the thumbs, oligodactyly of the feet</td></tr><tr><td align="left" rowspan="1" colspan="1">Other: sacral dimple</td></tr><tr><td align="center" rowspan="4" colspan="1"><bold>Radiographic Findings</bold></td><td align="left" rowspan="1" colspan="1">Craniofacial: mandibular hypoplasia</td><td align="left" rowspan="1" colspan="1">Craniofacial: mandibular hypoplasia</td><td align="left" rowspan="1" colspan="1">Craniofacial: midface hypoplasia with marked micrognathia</td></tr><tr><td align="left" rowspan="1" colspan="1">Axial:11 ribs</td><td align="left" rowspan="1" colspan="1">Axial: 11 ribs handlebar clavicles, hypoplastic scapulae, multiple cervical hemivertabrae, small ischia</td><td align="left" rowspan="1" colspan="1">Axial:11 ribs handlebar clavicles, hypoplastic scapulae, delayed ossification of the pubis</td></tr><tr><td align="left" rowspan="2" colspan="1">Extremities: hypoplastic radii, thumb hypoplasia, oligodactyly, shortened diaphyses of radii</td><td align="left" rowspan="2" colspan="1">Extremities: absent/ hypoplastic radii, thumb hypoplasia, oligodactyly, shortened diaphyses of radii, cervical vertebral anomalies</td><td align="left" rowspan="1" colspan="1">Extremities: brachydactyly, triphalangeal thumb with hypoplastic middle phalange, hypoplasia of humeri, humeroradial synostosis, long radii with thickened diaphyses, ulnar aplasia, bilateral hip dislocation, fibular aplasia, delayed ossification of the talus</td></tr><tr><td align="left" rowspan="1" colspan="1">Other: 11 ribs, sternal hypoplasia, abnormal ossification of the pelvis</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec005"><title>Family R08-269</title><p>The twin probands (ISDR cases R08-269A and B) were the offspring of a 33-year-old unaffected mother and an unaffected father. A prenatal ultrasound at 21 weeks gestation showed a monochorionic, diamniotic pregnancy, with both twins demonstrating limb abnormalities. There was significant size discordance between the twins, but both exhibited microcephaly, micrognathia and significant shortening of the appendicular bones, consistent with a form of acrofacial dysostosis. The pregnancy was interrupted at 22 weeks gestation. Postmortem findings confirmed the size discordance, facial dysmorphisms (<xref ref-type="fig" rid="pgen.1006307.g001">Fig 1</xref>), bilateral microtia, severe micrognathia, left equinovarus in twin A, and right equinvarus in twin B (<xref ref-type="table" rid="pgen.1006307.t001">Table 1</xref>) also observed on ultrasound. Radiographic abnormalities included small scapulae, hypoplasia of the radii and thumbs in both twins, oligodacytly in twin A, and cervical vertebral and rib anomalies in twin B (<xref ref-type="fig" rid="pgen.1006307.g001">Fig 1</xref> and <xref ref-type="table" rid="pgen.1006307.t001">Table 1</xref>). The clinical findings were overall less severe than classic Rodriguez syndrome, including case R14-123, but more severe than would be expected for Nager syndrome, leading to a diagnosis intermediate between Nager and Rodriguez syndromes.</p></sec></sec><sec id="sec006"><title>SF3B4 mutations cause Rodriguez syndrome</title><p>As <italic>SF3B4</italic> is frequently mutated in patients with Nager syndrome and it had been suggested that Rodriguez syndrome might be an allelic disorder [<xref rid="pgen.1006307.ref009" ref-type="bibr">9</xref>&#x02013;<xref rid="pgen.1006307.ref012" ref-type="bibr">12</xref>,<xref rid="pgen.1006307.ref014" ref-type="bibr">14</xref>,<xref rid="pgen.1006307.ref020" ref-type="bibr">20</xref>], we determined the sequences of <italic>SF3B4</italic> in the two cases. Case R14-123A, with Rodriguez syndrome, was heterozygous for a <italic>de novo</italic> single base insertion (c.614_615insG; p.Asp205Glufs*281) in exon 3 (<xref ref-type="fig" rid="pgen.1006307.g002">Fig 2A</xref>). Case R08-269B, with the intermediate phenotype, was heterozygous for a single base insertion (c.1060dupC; p.Arg354Profs*132) in exon 5 (<xref ref-type="fig" rid="pgen.1006307.g002">Fig 2B</xref>). The latter mutation was previously found in two cases of Nager syndrome [<xref rid="pgen.1006307.ref009" ref-type="bibr">9</xref>,<xref rid="pgen.1006307.ref012" ref-type="bibr">12</xref>]. Both mutations led to frameshifts which started at different positions within the coding region but resulted in stop codons that terminated at the same position, which was beyond the normal stop codon (<xref ref-type="fig" rid="pgen.1006307.g002">Fig 2D</xref>). Such mutations are referred to as a type of nonstop mutation and can lead to nonsense mediated decay of the transcripts [<xref rid="pgen.1006307.ref021" ref-type="bibr">21</xref>,<xref rid="pgen.1006307.ref022" ref-type="bibr">22</xref>]. Sequence analysis of amplified cDNA from R14-123A fibroblasts showed presence of some transcript derived from the mutant allele but always at a reduced level relative to the normal allele sequence (<xref ref-type="fig" rid="pgen.1006307.g002">Fig 2C</xref>), consistent with instability of the mutant transcript. Based on these findings, we concluded that <italic>SF3B4</italic> mutations cause Rodriguez syndrome.</p><fig id="pgen.1006307.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1006307.g002</object-id><label>Fig 2</label><caption><title>Mutations in <italic>SF3B4</italic>.</title><p>(A,B) Electropherogram representation of genomic DNA fragments from controls (top), (A) case R14-123A (bottom), (B) case R08-269B (bottom). (C) The insertion in the <italic>SF3B4</italic> cDNA of R14-123A (bottom) as compared with control (top). The positions of the insertion mutations are indicated by arrows. (D) Schematic diagram of predicted protein alterations caused by <italic>SF3B4</italic> frameshift mutations. The blue bars correspond to the reference amino acid sequence and the red bars indicate altered amino acid sequences that begin at the mutation site. RNA recognition motifs (RRM) are shown as purple ovals.</p></caption><graphic xlink:href="pgen.1006307.g002"/></fig></sec><sec id="sec007"><title>Decreased expression of SF3B4 transcript and protein in Rodriguez syndrome</title><p>To characterize the effect of the mutations on overall <italic>SF3B4</italic> expression, qRT-PCR was used to measure <italic>SF3B4</italic> mRNA levels in cultured fibroblasts from case R14-123A and in chondrocytes from case R08-269A. There was about a 30% reduction in SF3B4 transcripts in both cases compared with controls (<xref ref-type="fig" rid="pgen.1006307.g003">Fig 3A and 3B</xref>). As shown in <xref ref-type="fig" rid="pgen.1006307.g003">Fig 3C</xref>, for R14-123A there was a corresponding decrease in SF3B4 protein relative to the control. Because there was a low level of the mutant transcript, which is predicted to encode a protein with an altered carboxyl-terminus that extends the length of the protein by 60 amino acids, we attempted to detect the mutant protein. The predicted molecular weight of the elongated protein is 52.8 kDa, which is 8.4 kDa larger than wild-type (WT) SF3B4. Western blotting was performed using an antibody to the amino-terminal end of the protein, which should be unaltered in both normal and mutant SF3B4, and with an antibody directed against the carboxyl-terminal end, which should only recognize WT SF3B4. As shown in <xref ref-type="fig" rid="pgen.1006307.g003">Fig 3D</xref>, with a long exposure, the antibody against the amino-terminal end of the protein detected a faint protein migrating just above the SF3B4 WT protein, in a position corresponding to the predicted molecular weight of the mutant protein. This protein was not detected by the carboxyl-terminal antibody, as would be expected based on the mutation. The data were thus consistent with synthesis of a small amount of the mutant protein by the low level of mutant transcript present in the cultured cells (<xref ref-type="fig" rid="pgen.1006307.g002">Fig 2C</xref>). Whether the abnormal protein is functional and contributes to the U2 snRNP and the Rodriguez syndrome phenotype is unknown. Immunofluorescence staining of cultured fibroblasts revealed nuclear localization of SF3B4, in agreement with its spliceosomal function in nucleus, with the fluorescence intensity appropriately reduced in cultured cells from the affected individual (<xref ref-type="fig" rid="pgen.1006307.g003">Fig 3E</xref>).</p><fig id="pgen.1006307.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1006307.g003</object-id><label>Fig 3</label><caption><title>Decreased expression of SF3B4 in Rodriguez syndrome.</title><p>(A,B) Detection of <italic>SF3B4</italic> mRNA by quantitative RT-PCR in (A) R14-123A fibroblasts and (B) R08-269A chondrocytes. (C) Western blots (left panel) and signal quantification (right panel) of SF3B4 in R14-123A fibroblasts. Data in the bar graphs were collected from at least three replicates and were represented as mean&#x02009;&#x000b1;&#x02009;standard deviation. *p&#x0003c;0.05; **p&#x0003c;0.01. (D) Detection of SF3B4 protein in R14-123A fibroblasts by Western blotting with the antibodies against the N- and C-termini of the SF3B4 protein, respectively. The asterisk identifies the elongated form of SF3B4 that was presumed to be derived from the mutant allele. SF3B1 protein was used as a loading control. (E) Immunostaining of human fibroblasts with anti-SF3B4 (green). Cell nuclei were stained with DAPI (blue).</p></caption><graphic xlink:href="pgen.1006307.g003"/></fig></sec><sec id="sec008"><title>Disruption of growth plate architecture due to SF3B4 mutation</title><p>The affected individuals exhibited shortening or absence of humeri, radii and ulnae, brachydactyly, and delayed ossification of the talus (<xref ref-type="fig" rid="pgen.1006307.g001">Fig 1</xref> and <xref ref-type="table" rid="pgen.1006307.t001">Table 1</xref>), which all indicate defective endochondral ossification. We therefore performed histopathological examination of the distal femur growth plates. As shown in <xref ref-type="fig" rid="pgen.1006307.g004">Fig 4</xref>, both cases showed a dramatically reduced hypertrophic zone with disorganization of the normal columnar arrangement of chondrocytes. Mutant hypertrophic chondrocytes were also smaller than the corresponding control cells. Case R14-123A had the most severely disrupted morphology, in agreement with the more severe clinical and radiographic phenotype in this case.</p><fig id="pgen.1006307.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1006307.g004</object-id><label>Fig 4</label><caption><title>Pronounced disorganization of hypertrophic chondrocytes caused by <italic>SF3B4</italic> mutations.</title><p>Toluidine blue staining of the distal femur growth plate from (A) a control fetus, (B) R14-123A, (C) R08-269A and (D) R08-269B. The hypertrophic zone is marked with double arrows. Images were obtained at 20X magnification. Scale bars are 100 &#x003bc;M.</p></caption><graphic xlink:href="pgen.1006307.g004"/></fig></sec><sec id="sec009"><title>SF3B4 mutation dysregulates expression of skeletal developmental genes</title><p>Cartilage growth plate development is regulated by highly orchestrated cell signaling and transcriptional networks. Profound disorganization of the hypertrophic zone suggested impaired chondrocyte gene expression as a possible result of mutations in <italic>SF3B4</italic>. We therefore measured growth plate chondrocyte gene expression by RNA-seq using RNA derived from distal femur cartilage from case R08-269A. This analysis identified 2025 differentially expressed transcripts. Among them, 652 transcripts (representing 622 genes) were down-regulated and 1373 transcripts (representing 1215 genes) were up-regulated (<xref ref-type="supplementary-material" rid="pgen.1006307.s004">S2 Table</xref>). Gene ontology (GO) analysis of the down-regulated transcripts primarily revealed altered expression related to skeletal development, transcriptional regulation, chromosome organization and cell cycle control (<xref ref-type="fig" rid="pgen.1006307.g005">Fig 5A</xref>). Among the down-regulated genes, there were 15 genes, including <italic>DLX5</italic> and <italic>SOX6</italic>, that are known key regulators of skeletal development (<xref ref-type="table" rid="pgen.1006307.t002">Table 2</xref>, <xref ref-type="fig" rid="pgen.1006307.g005">Fig 5B and 5C</xref>). Since <italic>SOX9</italic> is is an upstream regulator of <italic>SOX6</italic> and plays a pivitol role in chondrocyte differentiation, we examined its expression in the RNA-seq data. As shown in <xref ref-type="fig" rid="pgen.1006307.g005">Fig 5D</xref>, <italic>SOX9</italic> is highly expressed in growth plate chondrocytes and its expression was reduced by 33% in the mutant growth plate. Thus while <italic>SOX9</italic> did not meet the screening criteria used to identify differentially expressed genes, its reduced expression was consistent with the secondary reduction of <italic>SOX6</italic> transcript levels observed in the RNA-seq data. The <italic>SF3B4</italic> transcript level was reduced by 32% in the mutant growth plate (<xref ref-type="fig" rid="pgen.1006307.g005">Fig 5E</xref>), a result concordant with the quantitative RT-PCR data (<xref ref-type="fig" rid="pgen.1006307.g003">Fig 3B</xref>).</p><fig id="pgen.1006307.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1006307.g005</object-id><label>Fig 5</label><caption><title>SF3B4 mutation leads to altered gene expression.</title><p>(A) GO analysis of down-regulated genes in growth plate chondrocytes from case R08-269A. The number of genes in each GO term is indicated. (B-E) Expression changes of (B) <italic>DLX5</italic>, (C) <italic>SOX6</italic>, (D) <italic>SOX9</italic> and (E) <italic>SF3B4</italic>. The gene expression is represented as FPKM values. (F) Real-time quantitative RT-PCR validation of the RNA-seq data. mRNA expression was normalized to <italic>GAPDH</italic>. **p&#x0003c;0.01. (G) From top to bottom, enriched <italic>DLX5</italic>, <italic>DLX6</italic>, <italic>SOX5</italic> and <italic>SOX9</italic> binding motifs among the promoter regions of the down-regulated genes. The p values for motif enrichment are shown in parentheses below each motif.</p></caption><graphic xlink:href="pgen.1006307.g005"/></fig><table-wrap id="pgen.1006307.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1006307.t002</object-id><label>Table 2</label><caption><title>Skeletal developmental genes with reduced expression in R08-269A.</title></caption><alternatives><graphic id="pgen.1006307.t002g" xlink:href="pgen.1006307.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Gene symbol</th><th align="left" rowspan="1" colspan="1">RefSeq transcript ID</th><th align="left" rowspan="1" colspan="1">Log2 fold-change</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>FGFR1</italic></td><td align="left" rowspan="1" colspan="1">NM_015850, NM_023105</td><td align="left" rowspan="1" colspan="1">-3.416721096</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>IHH</italic></td><td align="left" rowspan="1" colspan="1">NM_002181</td><td align="left" rowspan="1" colspan="1">-2.413989037</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>PRDX1</italic></td><td align="left" rowspan="1" colspan="1">NM_181696</td><td align="left" rowspan="1" colspan="1">-2.160981972</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>COL11A2</italic></td><td align="left" rowspan="1" colspan="1">NM_001163771</td><td align="left" rowspan="1" colspan="1">-2.154836698</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>SMAD1</italic></td><td align="left" rowspan="1" colspan="1">NM_005900</td><td align="left" rowspan="1" colspan="1">-1.916626325</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>NOG</italic></td><td align="left" rowspan="1" colspan="1">NM_005450</td><td align="left" rowspan="1" colspan="1">-1.900681894</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>DLX5</italic></td><td align="left" rowspan="1" colspan="1">NM_005221</td><td align="left" rowspan="1" colspan="1">-1.711034402</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>HOXA6</italic></td><td align="left" rowspan="1" colspan="1">NM_024014</td><td align="left" rowspan="1" colspan="1">-1.696180867</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>PKD1</italic></td><td align="left" rowspan="1" colspan="1">NM_000296</td><td align="left" rowspan="1" colspan="1">-1.609477294</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>SOX6</italic></td><td align="left" rowspan="1" colspan="1">NM_033326, NM_001145811</td><td align="left" rowspan="1" colspan="1">-1.395398328</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CHAD</italic></td><td align="left" rowspan="1" colspan="1">NM_001267</td><td align="left" rowspan="1" colspan="1">-1.301461477</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>EVC</italic></td><td align="left" rowspan="1" colspan="1">NM_153717</td><td align="left" rowspan="1" colspan="1">-1.197830659</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>PLEKHA1</italic></td><td align="left" rowspan="1" colspan="1">NM_001001974</td><td align="left" rowspan="1" colspan="1">-1.146495803</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>GLI2</italic></td><td align="left" rowspan="1" colspan="1">NM_005270</td><td align="left" rowspan="1" colspan="1">-1.016538107</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>ATP7A</italic></td><td align="left" rowspan="1" colspan="1">NM_000052</td><td align="left" rowspan="1" colspan="1">-1.011805878</td></tr></tbody></table></alternatives></table-wrap><p>To validate the RNA-seq data, we performed quantitative RT-PCR using the same mutant chondrocyte-derived RNA. The data confirmed the observed reduction in <italic>DLX5</italic>, <italic>SOX6</italic>, and <italic>SOX9</italic> transcript levels (<xref ref-type="fig" rid="pgen.1006307.g005">Fig 5F</xref>). The expression levels of other U2 snRNP components, <italic>SF3B1</italic> and <italic>SF3B2</italic>, did not show significant differences relative to control chondrocyte RNA. Because it has been shown that <italic>DLX6</italic> coordinates with <italic>DLX5</italic> in the regulation of craniofacial and limb development, we also examined <italic>DLX6</italic> expression using quantitative PCR. While <italic>DLX6</italic> had a low expression level in chondrocytes, and therefore did not meet inclusion criteria for determining whether it was differentially expressed in the RNA-seq analysis, by qRT-PCR its expression was significantly decreased in mutant growth plate derived cartilage RNA (<xref ref-type="fig" rid="pgen.1006307.g005">Fig 5F</xref>).</p><p>DLX5/6 proteins and SOX5/6/9 are transcription factors known to regulate chondrocyte gene expression and skeletogenesis [<xref rid="pgen.1006307.ref023" ref-type="bibr">23</xref>,<xref rid="pgen.1006307.ref024" ref-type="bibr">24</xref>]. SOX5 and SOX6 form dimers and recognize sequences with SOX and SOX-like binding sites [<xref rid="pgen.1006307.ref025" ref-type="bibr">25</xref>,<xref rid="pgen.1006307.ref026" ref-type="bibr">26</xref>]. We therefore asked whether their targets were enriched among the 652 down-regulated transcripts in SF3B4 mutant growth plate chondrocytes. As shown in <xref ref-type="fig" rid="pgen.1006307.g005">Fig 5G</xref>, DLX5, DLX6, SOX5 and SOX9 binding motifs were found to be significantly enriched among the promoter regions of the downregulated transcripts (<xref ref-type="supplementary-material" rid="pgen.1006307.s004">S2 Table</xref>), consistent with reduced target gene expression as a regulatory consequence of reduced expression of DLX5/6 and SOX6/9 proteins.</p><p>Immunohistochemical staining demonstrated co-localization of expression of SF3B4 and DLX5 in normal human fetal growth plate, with expression in all growth plate chondrocytes and overlapping regions of the periosteum, consistent with their roles in growth plate chondrocyte differentiation and cell signaling (<xref ref-type="fig" rid="pgen.1006307.g006">Fig 6</xref>). Concordant with their respective functions in splicing and transcription, SF3B4 and DLX5 were specifically localized in chondrocyte nuclei in both wildtype (<xref ref-type="fig" rid="pgen.1006307.g006">Fig 6</xref>) and mutant growth plates.</p><fig id="pgen.1006307.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1006307.g006</object-id><label>Fig 6</label><caption><title>SF3B4 and DLX5 are co-expressed in the human growth plate.</title><p>Immunohistochemical staining of the distal femur growth plate from a control fetus with (A) anti-SF3B4 and (B) anti-DLX5 antibodies. The hypertrophic zone is marked with double arrows. The periosteum is identified by white arrows. Images were obtained at 20X (SF3B4) and 10X (DLX5) magnification. Scale bars are 100 &#x003bc;M.</p></caption><graphic xlink:href="pgen.1006307.g006"/></fig></sec><sec id="sec010"><title>Altered RNA splicing in SF3B4 mutant chondrocytes</title><p>Because of the role SF3B4 plays in the U2 snRNP complex, the rMATS algorithm was applied to the RNAseq data to determine the effect of reduced SF3B4 on splicing [<xref rid="pgen.1006307.ref027" ref-type="bibr">27</xref>]. A total of 1541 significant differential alternative splicing events were identified, which included both exon exclusion (&#x00394;PSI&#x0003c;0) and exon inclusion (&#x00394;PSI&#x0003e;0) scenarios in case R08-269A compared with the controls. These events were divided among five different alternative splicing outcomes. The major effect was exon skipping, with 765 skipped exon (SE) events, including 412 exon exclusions and 353 exon inclusions (<xref ref-type="fig" rid="pgen.1006307.g007">Fig 7A</xref> and <xref ref-type="supplementary-material" rid="pgen.1006307.s005">S3 Table</xref>). The other four outcomes were 124 mutually exclusive exon (MXE), 134 alternative 5&#x02019; splice site (A5SS), 269 alternative 3&#x02019; splice site (A3SS) and 249 retained intron (RI) events, with a higher fraction of exon exclusions relative to inclusions (<xref ref-type="fig" rid="pgen.1006307.g007">Fig 7A</xref>).</p><fig id="pgen.1006307.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1006307.g007</object-id><label>Fig 7</label><caption><title>SF3B4 mutation leads to altered splicing.</title><p>(A) Bar graph representation of altered splicing events in case R08-269A. The number of events in each category is indicated, with exon exclusion to the left (blue bars) and exon inclusion to the right (red bars). (B) GO enrichment analysis of alternative splicing events. The number of genes in each GO term is shown. SE, skipped exon; MXE, mutually exclusive exon; A5SS, alternative 5&#x02019; splice site; A3SS, alternative 3&#x02019; splice site; RI, retained intron.</p></caption><graphic xlink:href="pgen.1006307.g007"/></fig><p>RPBJ, HIF1A, SMAD3, and IGF2R are known upstream regulators of <italic>SOX9</italic> expression. For all four genes, a minor proportion of their transcripts showed altered splicing, primarily exon skipping or activation of cryptic splice sites (<xref ref-type="supplementary-material" rid="pgen.1006307.s002">S2 Fig</xref>). Among these events, we focused on the abnormal splicing pattern for <italic>SMAD3</italic>, as its altered splicing was consistent with the observed reduced expression of <italic>SOX9</italic>. SMAD3 is a component of TGF-&#x003b2; signaling pathway and induces primary chondrogenesis when overexpressed in human mesenchymal stem cells (MSCs). SMAD3 also has been shown to associate with SOX9 on the <italic>COL2A1</italic> enhancer to promote <italic>SOX9</italic>-mediated transcriptional activity, and depletion of <italic>SMAD3</italic> in MSCs by siRNA reduces <italic>SOX9</italic> expression [<xref rid="pgen.1006307.ref028" ref-type="bibr">28</xref>,<xref rid="pgen.1006307.ref029" ref-type="bibr">29</xref>]. In case R08-269A, a proportion of <italic>SMAD3</italic> transcripts had either inclusion of exon 3 or increased transcription that started from exon 4. Exon 3 encodes a linker region that connects the MH1 and MH2 domains of SMAD3. The <italic>SMAD3</italic> splicing variant lacking exon 3 (<italic>SMAD3-&#x00394;3</italic>) is expressed in multiple human tissues and has positive transcriptional activity [<xref rid="pgen.1006307.ref030" ref-type="bibr">30</xref>]. The truncated <italic>Smad3</italic> isoform transcribed from an ATG site within exon 4 consists of 7 exons and encodes half of the linker region and the MH2 region. This isoform inhibits activin-induced activation of the FSH&#x003b2; promoter [<xref rid="pgen.1006307.ref031" ref-type="bibr">31</xref>]. Thus together the R08-269A transcripts had reduced expression of the <italic>SMAD3-&#x00394;3</italic> transcription activator and increased expression of 5&#x02019; truncated transcriptional repressor isoforms, consistent with reduced SMAD3 activity which could lead to reduced expression of <italic>SOX9</italic>.</p><p>Beyond these specific splicing changes, GO analysis of the overall differential alternative splicing events demonstrated enrichment of biological processes relevant to the SF3B4 mutant phenotype, including extracellular matrix organization, skeletal system development, and RNA processing (<xref ref-type="fig" rid="pgen.1006307.g007">Fig 7B</xref>). These data support a complex effect of altered RNA splicing on downstream gene expression that included signaling molecules, transcription factors and chromatin modifiers that are known to regulate genes essential for skeletal development. Our findings imply that these factors could contribute to the mechanism of disease, but how each molecule individually contributes to this complex phenotype will require development of tissue specific cellular and animal models.</p></sec></sec><sec sec-type="conclusions" id="sec011"><title>Discussion</title><p>Spliceosomes, large ribonucleoprotein complexes that remove introns from pre-mRNA molecules, are composed of a set of snRNPs, including the U1, U2, U4/U6, and U5 complexes. SF3B4 encodes a core protein in the mammalian SF3B complex, part of the U2-type spliceosome which acts to help tether the U2 snRNP to the branch site [<xref rid="pgen.1006307.ref032" ref-type="bibr">32</xref>]. The <italic>SF3B4</italic> mutations identified lead to reduced SF3B4 synthesis, altered pre-mRNA splicing and reduced gene expression, ultimately producing the defects in craniofacial and limb development observed in the SF3B4 disorders.</p><sec id="sec012"><title><italic>SF3B4</italic> haploinsufficiency and AFD</title><p>Haploinsufficiency for <italic>SF3B4</italic> is considered to be the major cause of Nager syndrome. In an analysis of 35 independent families with Nager syndrome, Bernier et al. identified 18 cases heterozygous for <italic>SF3B4</italic> mutations, including 14 frameshift and two nonsense mutations, indicating that dominant, loss-of-function mutations commonly produce the phenotype [<xref rid="pgen.1006307.ref009" ref-type="bibr">9</xref>]. Similarly, in the data presented here, two <italic>SF3B4</italic> mutations that were both predicted to result in SF3B4 molecules with altered and extended carboxyl-termini, produced similar but more severe acrofacial dysostosis phenotypes, including one case with the lethal Rodriguez syndrome phenotype. Such mutations are predicted to lead to nonsense-mediated decay of the transcript and in the one case examined the mutant transcript was largely degraded. Whether the small amount of remaining mutant mRNA and the small amount of the abnormal protein (<xref ref-type="fig" rid="pgen.1006307.g003">Fig 3D</xref>) synthesized by the cells could exert a dominant-negative or gain-of-function effect on the SF3B complex and contribute to the phenotype by altering the splicing function of the complex is unknown. However, it is noteworthy that a case of Nager syndrome with a <italic>de novo</italic> deletion at chromosome 1q21.2 that covers <italic>SF3B4</italic> has been described [<xref rid="pgen.1006307.ref033" ref-type="bibr">33</xref>], supporting <italic>SF3B4</italic> haploinsufficiency as the primary driver of the craniofacial and limb defects observed in these acrofacial dysostosis phenotypes. The clinical variability in expression across Nager syndrome cases with defects in SF3B4 does suggest that modifiers can influence the phenotype, so it may be that small differences in splicing activity could contribute measureably to phenotypic expression. Interestingly, even the monozygotic twins described here showed some variability in expression, with twin A exhibiting a more severe clinical and radiographic phenotype, suggesting that either epigenetic phenomena or small temporal developmental differences in gene expression can alter the clinical consequences of <italic>SF3B4</italic> mutations.</p></sec><sec id="sec013"><title>Transcriptional dysregulation by SF3B4 mutation</title><p>The RNA-seq data demonstrate that reduced SF3B4 activity can alter gene expression, as in growth plate chondrocytes there were 622 genes that showed reduced expression. Among these are genes known to regulate skeletal system development, consistent with the altered growth plate morphology observed in <italic>SF3B4</italic> phenotypes and the ongoing growth deficiency in these disorders. Particularly noteworthy were <italic>DLX5</italic> and <italic>SOX9</italic>, genes with reduced expression and for which mechanistic hypotheses can be advanced to explain some of the skeletal phenotypic features observed in the SF3B4 disorders.</p><p><italic>DLX5</italic> and its cis-linked paralogue <italic>DLX6</italic> are pivotal regulators of craniofacial and limb development. <italic>Dlx5</italic> knockout mice showed craniofacial abnormalities [<xref rid="pgen.1006307.ref034" ref-type="bibr">34</xref>] and <italic>Dlx5/6</italic><sup>&#x02212;/&#x02212;</sup> mutant embryos exhibited severe limb, craniofacial, and axial skeletal defects [<xref rid="pgen.1006307.ref035" ref-type="bibr">35</xref>,<xref rid="pgen.1006307.ref036" ref-type="bibr">36</xref>]. <italic>Dlx5</italic><sup>&#x02212;/&#x02212;</sup> mice showed a modest defect in chondrocyte hypertrophy in the long bones of the limbs [<xref rid="pgen.1006307.ref037" ref-type="bibr">37</xref>], while targeted deletion of both <italic>Dlx5</italic> and <italic>Dlx6</italic> resulted in more pronounced deficiencies in chondrocyte hypertrophy [<xref rid="pgen.1006307.ref036" ref-type="bibr">36</xref>], underscoring their co-regulatory roles in growth plate chondrocyte maturation and endochondral ossification. Reciprocally, forced overexpression of <italic>Dlx5</italic> in chondrocytes promoted hypertrophy and induced precocious ossification in the endochondral skeleton [<xref rid="pgen.1006307.ref038" ref-type="bibr">38</xref>,<xref rid="pgen.1006307.ref039" ref-type="bibr">39</xref>].</p><p>In humans, chromosomal rearrangements of the 7q21.3-q22.1 region harboring <italic>DLX5</italic>, <italic>DLX6</italic> and their regulatory elements (including enhancers) have been found in Split-hand/split-foot malformation 1 (SHFM1, OMIM 183600), indicating that structural abnormalities affecting both genes can produce SHFM1 [<xref rid="pgen.1006307.ref040" ref-type="bibr">40</xref>,<xref rid="pgen.1006307.ref041" ref-type="bibr">41</xref>]. Monoallelic deletion of only the <italic>DLX5/6</italic> locus in some cases indicated that <italic>DLX5/6</italic> haploinsufficiency can lead to SHFM1 [<xref rid="pgen.1006307.ref042" ref-type="bibr">42</xref>]. Point mutations in three SHFM1 families suggest that mutations in <italic>DLX5</italic> alone may be sufficient to produce the phenotype [<xref rid="pgen.1006307.ref043" ref-type="bibr">43</xref>&#x02013;<xref rid="pgen.1006307.ref045" ref-type="bibr">45</xref>]. These data support the idea that the approximately half normal <italic>DLX5/6</italic> expression resulting from <italic>SF3B4</italic> haploinsufficiency could produce the distal limb abnormalities observed in Nager and Rodriguez syndromes. In addition to the split-hand/split foot phenotype, SHFM1 cases can have craniofacial abnormalities, mesomelic limb malformations, hearing loss, and developmental delay. Since many of these features are shared by Rodriguez/Nager syndrome cases, including cleft palate, micrognathia, and hypoplasia/absence of the radii and fibulae, the reduction of <italic>DLX5</italic>/<italic>6</italic> expression that resulted from reduced <italic>SF3B4</italic> expression likely contributes to these aspects of the phenotype as well. Because <italic>DLX5/6</italic> transcripts were spliced normally, reduced expression of <italic>DLX5/6</italic> due to <italic>SF3B4</italic> mutation is likely to be indirect. Multiple mechanisms are known to regulate <italic>DLX5/6</italic> expression, including regulation by other transcription factors (e.g. <italic>p63</italic>, <italic>MEF2C</italic>) [<xref rid="pgen.1006307.ref035" ref-type="bibr">35</xref>,<xref rid="pgen.1006307.ref046" ref-type="bibr">46</xref>], by distal regulatory elements (enhancer and noncoding RNA) [<xref rid="pgen.1006307.ref047" ref-type="bibr">47</xref>&#x02013;<xref rid="pgen.1006307.ref051" ref-type="bibr">51</xref>] and by epigenetic mechanisms [<xref rid="pgen.1006307.ref052" ref-type="bibr">52</xref>,<xref rid="pgen.1006307.ref053" ref-type="bibr">53</xref>]. <italic>SF3B4</italic> mutations may interfere with one or more of these mechanisms and lead to dysregulation of <italic>DLX5/6</italic> gene expression.</p><p>SOX9 is a transcription factor that regulates skeletal development [<xref rid="pgen.1006307.ref054" ref-type="bibr">54</xref>&#x02013;<xref rid="pgen.1006307.ref057" ref-type="bibr">57</xref>]. Heterozygosity for mutations in <italic>SOX9</italic> produces campomelic dysplasia [<xref rid="pgen.1006307.ref054" ref-type="bibr">54</xref>,<xref rid="pgen.1006307.ref055" ref-type="bibr">55</xref>], a generally lethal skeletal dysplasia [<xref rid="pgen.1006307.ref058" ref-type="bibr">58</xref>]. Most mutations in campomelic dysplasia result in haploinsufficiency for <italic>SOX9</italic> and the phenotypic consequences include micrognathia and abnormal ears, as well as distinct skeletal abnormalities. The characteristic skeletal defects include a bell shaped thorax, eleven pairs of ribs, a lateral clavicular hook, hypoplastic scapulae, poor ossification of the pubis, hip dislocations, hypoplastic fibulae, poor ossification of the talus and club feet. The cases with <italic>SF3B4</italic> mutations studied here exhibited many of these findings, supporting the inference that the diminished expression of <italic>SOX9</italic> transcript due to <italic>SF3B4</italic> haploinsufficiency contributes to their skeletal abnormalities. Furthermore, it is known that the skeleton is exquisitively sensitive to SOX9 dosage. Mouse studies show that haploinsuffiency produces a skeletal phenotype similar to campomelic dysplasia in that <italic>Sox9</italic><sup><italic>+/-</italic></sup> mice show hypoplastic scapulae and thin pubic bones [<xref rid="pgen.1006307.ref059" ref-type="bibr">59</xref>]. Similar to the consequences of diminished <italic>DLX5/6</italic> expression, because <italic>SOX9</italic> transcripts appear to be spliced normally, the mechanism for diminished <italic>SOX9</italic> transcript may be indirect, but the remarkable phenotypic overlap supports the hypothesis that reduced <italic>SOX9</italic> expression has the predictable biological consequences in the <italic>SF3B4</italic> disorder phenotypes.</p><p>The disrupted hypertrophic zones of the patient growth plates (<xref ref-type="fig" rid="pgen.1006307.g004">Fig 4</xref>) raise the question of whether downregulation of <italic>SOX9</italic> and <italic>DLX5</italic> are the cause or consequence of the morphological abnormalities. According to previous studies, <italic>Sox9</italic> is expressed in reserve and proliferating chondrocytes but not in the hypertrophic zone [<xref rid="pgen.1006307.ref026" ref-type="bibr">26</xref>,<xref rid="pgen.1006307.ref060" ref-type="bibr">60</xref>], consistent with an effect on hypertrophic chondrocyte differentiation as a consequence of reduced SOX9. For <italic>Dlx5</italic>, the gene is expressed throughout the growth plate, including in differentiating proliferative chondrocytes as well as the prehypertrophic and hypertrophic zones [<xref rid="pgen.1006307.ref037" ref-type="bibr">37</xref>,<xref rid="pgen.1006307.ref039" ref-type="bibr">39</xref>,<xref rid="pgen.1006307.ref061" ref-type="bibr">61</xref>]. However, because the hypertrophic zone is much less cellular, loss of hypertrophic chondrocytes could not account for the approximately 50% reduction in <italic>DLX5</italic> transcripts. Thus the data again suggest that the morphological alterations are secondary to the reduced expression and not the other way around.</p></sec><sec id="sec014"><title>Splicing defects and AFD</title><p>The altered splicing and gene expression resulting from <italic>SF3B4</italic> mutations echo the spliceosomal defects that have been found to underlie other craniofacial disorders [<xref rid="pgen.1006307.ref006" ref-type="bibr">6</xref>]. Haploinsufficiency for <italic>EFTUD2</italic>, which encodes a GTPase in the U5 snRNP and has a regulatory role in catalytic splicing and post-splicing-complex disassembly, causes mandibulofacial dysostosis of the Guion-Almeida type (OMIM 610536), a disorder that shares many clinical features with Rodriguez/Nager syndromes [<xref rid="pgen.1006307.ref007" ref-type="bibr">7</xref>]. EFTUD2 has been shown to interact with SF3B4 by yeast two-hybrid and co-immunoprecipitation studies and it has been suggested that interactions between SF3B and U5 proteins may recruit the tri-snRNP (U4/U6-U5) complex to the spliceosome via the U2 complex [<xref rid="pgen.1006307.ref062" ref-type="bibr">62</xref>]. In this study, we identified 1541 alternative splicing events, predominantly exon skipping. As shown here, altered splicing has complex consequences, likely contributing both directly and indirectly to the AFD phenotype, a complexity underscored by alterations in expression of multiple transcription factors known to be essential for normal skeletal development. For the craniofacial dysmorphology in particular, knockdown of <italic>Sf3b4</italic> in Xenopus has been shown to result in loss of cranial neural crest cells, demonstrating the importance of normal splicing in maintaining craniofacial skeletal precursors during development [<xref rid="pgen.1006307.ref063" ref-type="bibr">63</xref>].</p><p>The limb deficiencies and craniofacial dysmophologies found in AFDs with spliceosomal defects indicate that altered splicing/expression of key regulators may lead to developmental abnormalities including early digit patterning and neural crest cell formation and proliferation defects [<xref rid="pgen.1006307.ref064" ref-type="bibr">64</xref>], neither of which would be revealed by studying growth plate chondrocytes. For example, <italic>p63</italic> is a master trancriptional regulator that controls <italic>DLX5/6</italic> expression and skeletogenesis [<xref rid="pgen.1006307.ref035" ref-type="bibr">35</xref>,<xref rid="pgen.1006307.ref065" ref-type="bibr">65</xref>,<xref rid="pgen.1006307.ref066" ref-type="bibr">66</xref>]. <italic>p63</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice show severely limb and craniofacial defects, and <italic>P63</italic> mutations lead to human disorders affecting the facial and limb structures [<xref rid="pgen.1006307.ref065" ref-type="bibr">65</xref>&#x02013;<xref rid="pgen.1006307.ref069" ref-type="bibr">69</xref>]. Multiple <italic>p63</italic> isoforms generated by alternative splicing and promoter usage have been identified, which show distinct roles during endochondral ossification [<xref rid="pgen.1006307.ref070" ref-type="bibr">70</xref>]. Therefore, mis-spliced <italic>p63</italic> may account for the down-regulation of <italic>DLX5/6</italic> in Rodriguez/Nager syndrome cases. However, <italic>p63</italic> expression was undetectable in growth plate chondroctyes, suggesting the possibility that earlier developmental events may have led to some of the observed effects on gene expression. Analysis of <italic>Sf3b4</italic> deficient animal models will help to identify novel regulators and clarify the role of <italic>Sf3b4</italic> in skeletogenesis at early developmental stages.</p><p>In addition to the links between splicing and AFD, other mechanisms may also contribute to the phenotype. In this context, SF3B4 has been shown to bind the bone morphogenetic protein (BMP) receptor BMPR-IA and specifically inhibit BMP-mediated osteochondral cell differentiation [<xref rid="pgen.1006307.ref071" ref-type="bibr">71</xref>,<xref rid="pgen.1006307.ref072" ref-type="bibr">72</xref>]. Thus reduced <italic>SF3B4</italic> expression could alter more than one developmental pathway to elicit the observed phenotypes. However, <italic>Xenopus Sf3b4</italic> knockdown studies did not confirm a link between SF3B4 expression and BMP signaling alterations [<xref rid="pgen.1006307.ref063" ref-type="bibr">63</xref>], indicative of unresolved certainty connecting the SF3B4 disorders and this important skeletal signaling pathway.</p><p>In summary, the current study identified heterozygosity for <italic>SF3B4</italic> mutations in one case of Rodriguez syndrome and second case with a phenotype intermediate between Rodriguez and Nager syndromes. These data demonstrate that Rodriguez syndrome is a dominant disorder that is allelic with Nager syndrome, and show that the two disorders belong to a spectrum unified by mutations in <italic>SF3B4</italic>. <italic>SF3B4</italic> mutations have also been found in an independent set of Rodriguez syndrome cases (New dominant mutations in SF3B4 encoding an mRNA spliceosomal protein important in embryonic limb patterning underlie Rodriguez acrofacial dysostosis. MD Irving, B Dimitrov, D Chitayat, JI Rodriguez, MW Wessels, MA Simpson. American Society of Human Genetics Meeting, 2014), further supporting this conclusion. Through RNA-seq analysis, mutant growth plate chondrocytes showed altered splicing and reduced expression of transcription factors and additional genes essential for skeletogenesis, suggesting specific regulatory mechanisms that are disrupted in the <italic>SF3B4</italic> disorders. Elucidating the direct and indirect effects on the regulatory gene expression pathways affected by <italic>SF3B4</italic> mutations is expected to reveal the developmental hierarchy that defines when and how skeletogenesis is altered to produce the SF3B4 phenotypes.</p></sec></sec><sec sec-type="materials|methods" id="sec015"><title>Materials and Methods</title><sec id="sec016"><title>Ethics statement</title><p>Cases were recruited and informed consent obtained under a UCLA-approved human subjects protocol, through which clinical evaluation and imaging studies, as well as tissue procurement, were carried out.</p></sec><sec id="sec017"><title>Cartilage specimen collection and cell culture</title><p>Chondrocytes were isolated from distal femur growth plate cartilage from case R08-269A and four independent 14&#x02013;18 week normal fetal growth plates as described previously [<xref rid="pgen.1006307.ref073" ref-type="bibr">73</xref>]. Skin fibroblast cultures were established from explanted skin biopsies from case R14-123A and an unaffected 26-week fetus. Fibroblasts were grown at 37&#x000b0;C in Dulbecco's modified Eagle&#x02019;s medium plus 10% FBS, penicillin, and streptomycin in 5% CO<sub>2</sub>.</p></sec><sec id="sec018"><title>Genomic DNA isolation and Sanger sequencing</title><p>Genomic DNA was isolated from cultured fibroblasts using the QIAamp DNA Mini Kit (Qiagen) according to the manufacturer&#x02019;s protocol. PCR products were generated with primers flanking each coding exon of <italic>SF3B4</italic> (<xref ref-type="supplementary-material" rid="pgen.1006307.s003">S1 Table</xref>) and their sequences determined by bidirectional Sanger sequencing. Electropherograms were analyzed using the CLC Main Workbench (CLC Bio). DNA sequences were compared with the <italic>SF3B4</italic> reference genomic sequence (NCBI accession number NG_032777.1).</p></sec><sec id="sec019"><title>RNA isolation and quantitative PCR</title><p>RNA was isolated from fibroblasts and chondrocytes with TRIZol (Thermo Fisher Scientific) and DNA contamination removed with DNase I (Thermo Fisher Scientific). RNA was reverse transcribed using the SuperScript III First-Strand Synthesis System (Thermo Fisher Scientific). Quantitative real-time PCR was performed using SYBR Green Real-Time PCR Master Mix (Thermo Fisher Scientific). Primer sequences for the target genes are listed in the <xref ref-type="supplementary-material" rid="pgen.1006307.s003">S1 Table</xref>. <italic>GAPDH</italic> was used as a reference gene for normalization. Gene expression was quantified with the &#x00394;&#x00394;CT method [<xref rid="pgen.1006307.ref074" ref-type="bibr">74</xref>]. Statistical significance was assessed using two-sample Student&#x02019;s <italic>t</italic>-test. Sequences of PCR products were determined by Sanger sequence analysis and compared with the NCBI <italic>SF3B4</italic> reference sequence (NCBI accession number NM_005850.4).</p></sec><sec id="sec020"><title>Western blotting</title><p>Cells were lysed in RIPA buffer and proteins separated by electrophoresis on SDS-PAGE gels (Bio-Rad). Proteins were transferred to membranes and probed with anti-SF3B1 (Abcam, ab172634, 1:1000 dilution), anti-SF3B4 N-terminal (Proteintech, 10482-1-AP, 1:1000 dilution), anti-SF3B4 C-terminal (Bethyl Laboratories, A303-950A, 1:1000 dilution) or anti-GAPDH (Cell Signaling Technology, 2118, 1:10000 dilution) antibodies. The ECL kit (Thermo Fisher Scientific) was used to visualize immunoreactive proteins. The level of SF3B4 was quantified with ImageJ software and normalized by comparison with the expression of GAPDH.</p></sec><sec id="sec021"><title>Cellular immunofluorescence</title><p>Cultured fibroblasts were fixed in 4% PFA, followed by three washes with PBS and one wash with PBST (1% Triton X-100 in PBS). The samples were then blocked in 10% goat serum for 1h and incubated overnight with anti-SF3B4 polyclonal antibody (Proteintech, 10482-1-AP 1:50 dilution). Cell images were captured using confocal fluorescence microscopy (Zeiss).</p></sec><sec id="sec022"><title>Cartilage morphology and immunohistochemistry</title><p>For Toluidine Blue staining, fetal cartilage samples were fixed in 10% buffered formalin overnight, then washed and transferred to 70% ethanol, dehydrated and embedded without decalcification in methyl methacrylate. The cartilage sections were stained with 0.1% Toluidine Blue. For immunohistochemistry, the paraffin embedded sections were deparaffinized, rehydrated in an ethanol series and permeablilized in 0.5% Triton X-100 before blocking in 10% goat serum and incubating with the primary antibody. The anti-SF3B4 (Proteintech, 10482-1-AP, 1:50 dilution) and anti-DLX5 (Sigma-Aldrich, HPA005670, 1:150 dilution) antibodies were used for staining. The sections were developed with 3,3'-diaminobenzidine (DAB) solution.</p></sec><sec id="sec023"><title>RNA-seq and data processing</title><p>Total RNA was isolated with TRIZol (Thermo Fisher Scientific) from distal femur growth plate chondrocytes from case R08-269A and four independent 14&#x02013;18 week fetuses. DNA contamination was removed by DNase I (Thermo Fisher Scientific) digestion at 37&#x000b0;C for 30 minutes. The RNA was further purified with the RNeasy Mini Kit (Qiagen). Total RNA samples with RIN (RNA integrity) numbers &#x02265; 8 (measured with the Agilent 2100 BioAnalyzer) were used for mRNA library preparation using the TruSeq RNA Preparation Kit (Illumina) according to the manufacturer's instructions. 75bp paired-end reads were generated on the HiSeq 2000 or NextSeq 500 sequencer (Illumina).</p><p>RNA-seq reads were mapped to the human genome (hg19) using TopHat (v2.0.9), allowing up to 2-bp mismatches per read [<xref rid="pgen.1006307.ref075" ref-type="bibr">75</xref>]. Cufflinks (v2.2.1) was used to calculate RNA-seq based gene expression levels using the FPKM value (fragments per kilobase of exon per million fragments mapped) [<xref rid="pgen.1006307.ref076" ref-type="bibr">76</xref>]. Low abundance genes with FPKM values less than 1 were filtered before further analysis. The differentially expressed genes in the case were defined as those genes with more than a 2-fold change in FPKM value compared with the average FPKM value of the normal control samples and more than a 1.5-fold change of FPKM value compared with the maximum or minimum FPKM value of the controls. rMATS (v3.2.1) was used to identify differential alternative splicing events between the case and controls [<xref rid="pgen.1006307.ref027" ref-type="bibr">27</xref>]. The change in Percent Spliced In (&#x00394;PSI or &#x00394;&#x003c8;) and false discovery rate (FDR) were used to identify the most significant altered splicing events. The alternative splicing events were filtered using |&#x00394;PSI| &#x0003e; 0.05, FDR &#x0003c; 0.05 and at least 10 reads covering the exon-exon junctions in both case and control samples. Genes with differential expression or alternative splicing were submitted to DAVID for Gene Ontology (GO) analysis [<xref rid="pgen.1006307.ref077" ref-type="bibr">77</xref>].</p></sec><sec id="sec024"><title>Motif analysis</title><p>Enrichment analysis of known transcription factor binding motifs was performed with CentriMo v4.11.1 in the MEME suite [<xref rid="pgen.1006307.ref078" ref-type="bibr">78</xref>] using the DNA sequences from gene promoter regions (&#x000b1;1Kb from transcription start sites). Known motifs were obtained from the HOmo sapiens COmprehensive MOdel COllection (HOCOMOCO) v10 [<xref rid="pgen.1006307.ref079" ref-type="bibr">79</xref>]. Match score &#x02265; 5 and E-value &#x02264; 10 were selected as the report threshold.</p></sec></sec><sec sec-type="supplementary-material" id="sec025"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pgen.1006307.s001"><label>S1 Fig</label><caption><title>Prenatal ultrasound images for case R14-123A.</title><p>(A,B). Profile showing severe retrognathia and malar hypoplasia. (C) Preaxial polydactyly of the hand (arrow). (D) Low set ears (arrow). (E) Humeral-radial fusion. (F) Bilateral lower extremities showing shortened tibiae and absent fibulae.</p><p>(TIF)</p></caption><media xlink:href="pgen.1006307.s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1006307.s002"><label>S2 Fig</label><caption><title>Altered RNA splicing in growth plate chondrocytes.</title><p>Sashimi plots of alternatively spliced and flanking exons of (A) <italic>SMAD3</italic>, (B) <italic>IGF2R</italic>, (C) <italic>RBPJ</italic>, and (D) <italic>HIF1A</italic>. The number of junction reads is indicated within segments. Altered splicing events are indicated by arrows. Exons are numbered and shown at the bottom.</p><p>(TIF)</p></caption><media xlink:href="pgen.1006307.s002.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1006307.s003"><label>S1 Table</label><caption><title>Sequences of primers used in this study.</title><p>(XLSX)</p></caption><media xlink:href="pgen.1006307.s003.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1006307.s004"><label>S2 Table</label><caption><title>Gene expression in growth plate chondrocytes and motif analysis.</title><p>(XLSX)</p></caption><media xlink:href="pgen.1006307.s004.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1006307.s005"><label>S3 Table</label><caption><title>Alternative splicing events in growth plate chondrocytes from case R08-269A.</title><p>(XLSX)</p></caption><media xlink:href="pgen.1006307.s005.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank the families who participated in the study. We thank the UCLA High-Throughput Sequencing Core in the Broad Stem Cell Research Center and the UCLA Clinical Microarray Core for their assistance with high-throughput sequencing. We thank Tracy Johnson for critically reviewing the manuscript. We are grateful to Melita Irving for sharing data prior to publication.</p></ack><ref-list><title>References</title><ref id="pgen.1006307.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Wieczorek</surname><given-names>D</given-names></name> (<year>2013</year>) <article-title>Human facial dysostoses</article-title>. <source>Clin Genet</source>
<volume>83</volume>: <fpage>499</fpage>&#x02013;<lpage>510</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/cge.12123">10.1111/cge.12123</ext-link></comment>
<?supplied-pmid 23565775?><pub-id pub-id-type="pmid">23565775</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>SB</given-names></name>, <name><surname>Buckingham</surname><given-names>KJ</given-names></name>, <name><surname>Lee</surname><given-names>C</given-names></name>, <name><surname>Bigham</surname><given-names>AW</given-names></name>, <name><surname>Tabor</surname><given-names>HK</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Exome sequencing identifies the cause of a mendelian disorder</article-title>. <source>Nat Genet</source>
<volume>42</volume>: <fpage>30</fpage>&#x02013;<lpage>35</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.499">10.1038/ng.499</ext-link></comment>
<?supplied-pmid 19915526?><pub-id pub-id-type="pmid">19915526</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Ruiz-Perez</surname><given-names>VL</given-names></name>, <name><surname>Ide</surname><given-names>SE</given-names></name>, <name><surname>Strom</surname><given-names>TM</given-names></name>, <name><surname>Lorenz</surname><given-names>B</given-names></name>, <name><surname>Wilson</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis</article-title>. <source>Nat Genet</source>
<volume>24</volume>: <fpage>283</fpage>&#x02013;<lpage>286</lpage>. <?supplied-pmid 10700184?><pub-id pub-id-type="pmid">10700184</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Ye</surname><given-names>X</given-names></name>, <name><surname>Song</surname><given-names>G</given-names></name>, <name><surname>Fan</surname><given-names>M</given-names></name>, <name><surname>Shi</surname><given-names>L</given-names></name>, <name><surname>Jabs</surname><given-names>EW</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>A novel heterozygous deletion in the EVC2 gene causes Weyers acrofacial dysostosis</article-title>. <source>Hum Genet</source>
<volume>119</volume>: <fpage>199</fpage>&#x02013;<lpage>205</lpage>. <?supplied-pmid 16404586?><pub-id pub-id-type="pmid">16404586</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Weaver</surname><given-names>KN</given-names></name>, <name><surname>Watt</surname><given-names>KE</given-names></name>, <name><surname>Hufnagel</surname><given-names>RB</given-names></name>, <name><surname>Navajas Acedo</surname><given-names>J</given-names></name>, <name><surname>Linscott</surname><given-names>LL</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction</article-title>. <source>Am J Hum Genet</source>
<volume>96</volume>: <fpage>765</fpage>&#x02013;<lpage>774</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajhg.2015.03.011">10.1016/j.ajhg.2015.03.011</ext-link></comment>
<?supplied-pmid 25913037?><pub-id pub-id-type="pmid">25913037</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Lehalle</surname><given-names>D</given-names></name>, <name><surname>Wieczorek</surname><given-names>D</given-names></name>, <name><surname>Zechi-Ceide</surname><given-names>RM</given-names></name>, <name><surname>Passos-Bueno</surname><given-names>MR</given-names></name>, <name><surname>Lyonnet</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>A review of craniofacial disorders caused by spliceosomal defects</article-title>. <source>Clin Genet</source>
<volume>88</volume>: <fpage>405</fpage>&#x02013;<lpage>415</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/cge.12596">10.1111/cge.12596</ext-link></comment>
<?supplied-pmid 25865758?><pub-id pub-id-type="pmid">25865758</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Lines</surname><given-names>MA</given-names></name>, <name><surname>Huang</surname><given-names>L</given-names></name>, <name><surname>Schwartzentruber</surname><given-names>J</given-names></name>, <name><surname>Douglas</surname><given-names>SL</given-names></name>, <name><surname>Lynch</surname><given-names>DC</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Haploinsufficiency of a spliceosomal GTPase encoded by EFTUD2 causes mandibulofacial dysostosis with microcephaly</article-title>. <source>Am J Hum Genet</source>
<volume>90</volume>: <fpage>369</fpage>&#x02013;<lpage>377</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajhg.2011.12.023">10.1016/j.ajhg.2011.12.023</ext-link></comment>
<?supplied-pmid 22305528?><pub-id pub-id-type="pmid">22305528</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Favaro</surname><given-names>FP</given-names></name>, <name><surname>Alvizi</surname><given-names>L</given-names></name>, <name><surname>Zechi-Ceide</surname><given-names>RM</given-names></name>, <name><surname>Bertola</surname><given-names>D</given-names></name>, <name><surname>Felix</surname><given-names>TM</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>A noncoding expansion in EIF4A3 causes Richieri-Costa-Pereira syndrome, a craniofacial disorder associated with limb defects</article-title>. <source>Am J Hum Genet</source>
<volume>94</volume>: <fpage>120</fpage>&#x02013;<lpage>128</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajhg.2013.11.020">10.1016/j.ajhg.2013.11.020</ext-link></comment>
<?supplied-pmid 24360810?><pub-id pub-id-type="pmid">24360810</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Bernier</surname><given-names>FP</given-names></name>, <name><surname>Caluseriu</surname><given-names>O</given-names></name>, <name><surname>Ng</surname><given-names>S</given-names></name>, <name><surname>Schwartzentruber</surname><given-names>J</given-names></name>, <name><surname>Buckingham</surname><given-names>KJ</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome</article-title>. <source>Am J Hum Genet</source>
<volume>90</volume>: <fpage>925</fpage>&#x02013;<lpage>933</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajhg.2012.04.004">10.1016/j.ajhg.2012.04.004</ext-link></comment>
<?supplied-pmid 22541558?><pub-id pub-id-type="pmid">22541558</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Castori</surname><given-names>M</given-names></name>, <name><surname>Bottillo</surname><given-names>I</given-names></name>, <name><surname>D'Angelantonio</surname><given-names>D</given-names></name>, <name><surname>Morlino</surname><given-names>S</given-names></name>, <name><surname>De Bernardo</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>A 22-Week-Old Fetus with Nager Syndrome and Congenital Diaphragmatic Hernia due to a Novel SF3B4 Mutation</article-title>. <source>Mol Syndromol</source>
<volume>5</volume>: <fpage>241</fpage>&#x02013;<lpage>244</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000365769">10.1159/000365769</ext-link></comment>
<?supplied-pmid 25337072?><pub-id pub-id-type="pmid">25337072</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Czeschik</surname><given-names>JC</given-names></name>, <name><surname>Voigt</surname><given-names>C</given-names></name>, <name><surname>Alanay</surname><given-names>Y</given-names></name>, <name><surname>Albrecht</surname><given-names>B</given-names></name>, <name><surname>Avci</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Clinical and mutation data in 12 patients with the clinical diagnosis of Nager syndrome</article-title>. <source>Hum Genet</source>
<volume>132</volume>: <fpage>885</fpage>&#x02013;<lpage>898</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00439-013-1295-2">10.1007/s00439-013-1295-2</ext-link></comment>
<?supplied-pmid 23568615?><pub-id pub-id-type="pmid">23568615</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Petit</surname><given-names>F</given-names></name>, <name><surname>Escande</surname><given-names>F</given-names></name>, <name><surname>Jourdain</surname><given-names>AS</given-names></name>, <name><surname>Porchet</surname><given-names>N</given-names></name>, <name><surname>Amiel</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Nager syndrome: confirmation of SF3B4 haploinsufficiency as the major cause</article-title>. <source>Clin Genet</source>
<volume>86</volume>: <fpage>246</fpage>&#x02013;<lpage>251</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/cge.12259">10.1111/cge.12259</ext-link></comment>
<?supplied-pmid 24003905?><pub-id pub-id-type="pmid">24003905</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Dimitrov</surname><given-names>B</given-names></name>, <name><surname>Balikova</surname><given-names>I</given-names></name>, <name><surname>Jekova</surname><given-names>N</given-names></name>, <name><surname>Vakrilova</surname><given-names>L</given-names></name>, <name><surname>Fryns</surname><given-names>JP</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Acrofacial dysostosis type Rodriguez</article-title>. <source>Am J Med Genet A</source>
<volume>135</volume>: <fpage>81</fpage>&#x02013;<lpage>85</lpage>. <?supplied-pmid 15793832?><pub-id pub-id-type="pmid">15793832</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>McPherson</surname><given-names>E</given-names></name>, <name><surname>Zaleski</surname><given-names>C</given-names></name>, <name><surname>Ye</surname><given-names>Z</given-names></name>, <name><surname>Lin</surname><given-names>S</given-names></name> (<year>2014</year>) <article-title>Rodriguez syndrome with SF3B4 mutation: a severe form of Nager syndrome?</article-title>
<source>Am J Med Genet A</source>
<volume>164A</volume>: <fpage>1841</fpage>&#x02013;<lpage>1845</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ajmg.a.36555">10.1002/ajmg.a.36555</ext-link></comment>
<?supplied-pmid 24715698?><pub-id pub-id-type="pmid">24715698</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Miyawaki</surname><given-names>M</given-names></name>, <name><surname>Higuchi</surname><given-names>R</given-names></name>, <name><surname>Yoshikawa</surname><given-names>N</given-names></name> (<year>2009</year>) <article-title>Rodriguez lethal acrofacial dysostosis syndrome with pulmonary hypoplasia</article-title>. <source>Pediatr Int</source>
<volume>51</volume>: <fpage>593</fpage>&#x02013;<lpage>595</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1442-200X.2009.02874.x">10.1111/j.1442-200X.2009.02874.x</ext-link></comment>
<?supplied-pmid 19674374?><pub-id pub-id-type="pmid">19674374</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Petit</surname><given-names>P</given-names></name>, <name><surname>Moerman</surname><given-names>P</given-names></name>, <name><surname>Fryns</surname><given-names>JP</given-names></name> (<year>1992</year>) <article-title>Acrofacial dysostosis syndrome type Rodriguez: a new lethal MCA syndrome</article-title>. <source>Am J Med Genet</source>
<volume>42</volume>: <fpage>343</fpage>&#x02013;<lpage>345</lpage>. <?supplied-pmid 1536176?><pub-id pub-id-type="pmid">1536176</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Rodriguez</surname><given-names>JI</given-names></name>, <name><surname>Palacios</surname><given-names>J</given-names></name>, <name><surname>Urioste</surname><given-names>M</given-names></name> (<year>1990</year>) <article-title>New acrofacial dysostosis syndrome in 3 sibs</article-title>. <source>Am J Med Genet</source>
<volume>35</volume>: <fpage>484</fpage>&#x02013;<lpage>489</lpage>. <?supplied-pmid 2333875?><pub-id pub-id-type="pmid">2333875</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Sermer</surname><given-names>D</given-names></name>, <name><surname>Quercia</surname><given-names>N</given-names></name>, <name><surname>Chong</surname><given-names>K</given-names></name>, <name><surname>Chitayat</surname><given-names>D</given-names></name> (<year>2007</year>) <article-title>Acrofacial dysostosis syndrome type Rodriguez: prenatal diagnosis and autopsy findings</article-title>. <source>Am J Med Genet A</source>
<volume>143A</volume>: <fpage>3286</fpage>&#x02013;<lpage>3289</lpage>. <?supplied-pmid 18000904?><pub-id pub-id-type="pmid">18000904</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Wessels</surname><given-names>MW</given-names></name>, <name><surname>Den Hollander</surname><given-names>NS</given-names></name>, <name><surname>Cohen-Overbeek</surname><given-names>TE</given-names></name>, <name><surname>Lesnik</surname><given-names>Oberstein MS</given-names></name>, <name><surname>Nash</surname><given-names>RM</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Prenatal diagnosis and confirmation of the acrofacial dysostosis syndrome type Rodriguez</article-title>. <source>Am J Med Genet</source>
<volume>113</volume>: <fpage>97</fpage>&#x02013;<lpage>100</lpage>. <?supplied-pmid 12400073?><pub-id pub-id-type="pmid">12400073</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Ansart-Franquet</surname><given-names>H</given-names></name>, <name><surname>Houfflin-Debarge</surname><given-names>V</given-names></name>, <name><surname>Ghoumid</surname><given-names>J</given-names></name>, <name><surname>Pasz</surname><given-names>N</given-names></name>, <name><surname>Devisme</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Prenatal diagnosis of Nager syndrome in a monochorionic-diamniotic twin pregnancy</article-title>. <source>Prenat Diagn</source>
<volume>29</volume>: <fpage>187</fpage>&#x02013;<lpage>189</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/pd.2214">10.1002/pd.2214</ext-link></comment>
<?supplied-pmid 19180573?><pub-id pub-id-type="pmid">19180573</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Frischmeyer</surname><given-names>PA</given-names></name>, <name><surname>van Hoof</surname><given-names>A</given-names></name>, <name><surname>O'Donnell</surname><given-names>K</given-names></name>, <name><surname>Guerrerio</surname><given-names>AL</given-names></name>, <name><surname>Parker</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>An mRNA surveillance mechanism that eliminates transcripts lacking termination codons</article-title>. <source>Science</source>
<volume>295</volume>: <fpage>2258</fpage>&#x02013;<lpage>2261</lpage>. <?supplied-pmid 11910109?><pub-id pub-id-type="pmid">11910109</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Shoemaker</surname><given-names>CJ</given-names></name>, <name><surname>Green</surname><given-names>R</given-names></name> (<year>2012</year>) <article-title>Translation drives mRNA quality control</article-title>. <source>Nat Struct Mol Biol</source>
<volume>19</volume>: <fpage>594</fpage>&#x02013;<lpage>601</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nsmb.2301">10.1038/nsmb.2301</ext-link></comment>
<?supplied-pmid 22664987?><pub-id pub-id-type="pmid">22664987</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>CF</given-names></name>, <name><surname>Lefebvre</surname><given-names>V</given-names></name> (<year>2015</year>) <article-title>The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis</article-title>. <source>Nucleic Acids Res</source>
<volume>43</volume>: <fpage>8183</fpage>&#x02013;<lpage>8203</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkv688">10.1093/nar/gkv688</ext-link></comment>
<?supplied-pmid 26150426?><pub-id pub-id-type="pmid">26150426</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Hu</surname><given-names>G</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Sciavolino</surname><given-names>P</given-names></name>, <name><surname>Iler</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism</article-title>. <source>Mol Cell Biol</source>
<volume>17</volume>: <fpage>2920</fpage>&#x02013;<lpage>2932</lpage>. <?supplied-pmid 9111364?><pub-id pub-id-type="pmid">9111364</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>Y</given-names></name>, <name><surname>Lefebvre</surname><given-names>V</given-names></name> (<year>2008</year>) <article-title>L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer</article-title>. <source>Mol Cell Biol</source>
<volume>28</volume>: <fpage>4999</fpage>&#x02013;<lpage>5013</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/MCB.00695-08">10.1128/MCB.00695-08</ext-link></comment>
<?supplied-pmid 18559420?><pub-id pub-id-type="pmid">18559420</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Lefebvre</surname><given-names>V</given-names></name>, <name><surname>Li</surname><given-names>P</given-names></name>, <name><surname>de Crombrugghe</surname><given-names>B</given-names></name> (<year>1998</year>) <article-title>A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene</article-title>. <source>EMBO J</source>
<volume>17</volume>: <fpage>5718</fpage>&#x02013;<lpage>5733</lpage>. <?supplied-pmid 9755172?><pub-id pub-id-type="pmid">9755172</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Shen</surname><given-names>S</given-names></name>, <name><surname>Park</surname><given-names>JW</given-names></name>, <name><surname>Lu</surname><given-names>ZX</given-names></name>, <name><surname>Lin</surname><given-names>L</given-names></name>, <name><surname>Henry</surname><given-names>MD</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>111</volume>: <fpage>E5593</fpage>&#x02013;<lpage>5601</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1419161111">10.1073/pnas.1419161111</ext-link></comment>
<?supplied-pmid 25480548?><pub-id pub-id-type="pmid">25480548</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Furumatsu</surname><given-names>T</given-names></name>, <name><surname>Ozaki</surname><given-names>T</given-names></name>, <name><surname>Asahara</surname><given-names>H</given-names></name> (<year>2009</year>) <article-title>Smad3 activates the Sox9-dependent transcription on chromatin</article-title>. <source>Int J Biochem Cell Biol</source>
<volume>41</volume>: <fpage>1198</fpage>&#x02013;<lpage>1204</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.biocel.2008.10.032">10.1016/j.biocel.2008.10.032</ext-link></comment>
<?supplied-pmid 19041414?><pub-id pub-id-type="pmid">19041414</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Furumatsu</surname><given-names>T</given-names></name>, <name><surname>Tsuda</surname><given-names>M</given-names></name>, <name><surname>Taniguchi</surname><given-names>N</given-names></name>, <name><surname>Tajima</surname><given-names>Y</given-names></name>, <name><surname>Asahara</surname><given-names>H</given-names></name> (<year>2005</year>) <article-title>Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment</article-title>. <source>J Biol Chem</source>
<volume>280</volume>: <fpage>8343</fpage>&#x02013;<lpage>8350</lpage>. <?supplied-pmid 15623506?><pub-id pub-id-type="pmid">15623506</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Kjellman</surname><given-names>C</given-names></name>, <name><surname>Honeth</surname><given-names>G</given-names></name>, <name><surname>Jarnum</surname><given-names>S</given-names></name>, <name><surname>Lindvall</surname><given-names>M</given-names></name>, <name><surname>Darabi</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Identification and characterization of a human smad3 splicing variant lacking part of the linker region</article-title>. <source>Gene</source>
<volume>327</volume>: <fpage>141</fpage>&#x02013;<lpage>152</lpage>. <?supplied-pmid 14980711?><pub-id pub-id-type="pmid">14980711</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>SY</given-names></name>, <name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Woodruff</surname><given-names>TK</given-names></name> (<year>2011</year>) <article-title>A truncated, activin-induced Smad3 isoform acts as a transcriptional repressor of FSHbeta expression in mouse pituitary</article-title>. <source>Mol Cell Endocrinol</source>
<volume>342</volume>: <fpage>64</fpage>&#x02013;<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.mce.2011.05.036">10.1016/j.mce.2011.05.036</ext-link></comment>
<?supplied-pmid 21664424?><pub-id pub-id-type="pmid">21664424</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Champion-Arnaud</surname><given-names>P</given-names></name>, <name><surname>Reed</surname><given-names>R</given-names></name> (<year>1994</year>) <article-title>The prespliceosome components SAP 49 and SAP 145 interact in a complex implicated in tethering U2 snRNP to the branch site</article-title>. <source>Genes Dev</source>
<volume>8</volume>: <fpage>1974</fpage>&#x02013;<lpage>1983</lpage>. <?supplied-pmid 7958871?><pub-id pub-id-type="pmid">7958871</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Lund</surname><given-names>IC</given-names></name>, <name><surname>Vestergaard</surname><given-names>EM</given-names></name>, <name><surname>Christensen</surname><given-names>R</given-names></name>, <name><surname>Uldbjerg</surname><given-names>N</given-names></name>, <name><surname>Becher</surname><given-names>N</given-names></name> (<year>2016</year>) <article-title>Prenatal diagnosis of Nager syndrome in a 12-week-old fetus with a whole gene deletion of SF3B4 by chromosomal microarray</article-title>. <source>Eur J Med Genet</source>
<volume>59</volume>: <fpage>48</fpage>&#x02013;<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejmg.2015.12.001">10.1016/j.ejmg.2015.12.001</ext-link></comment>
<?supplied-pmid 26679067?><pub-id pub-id-type="pmid">26679067</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Acampora</surname><given-names>D</given-names></name>, <name><surname>Merlo</surname><given-names>GR</given-names></name>, <name><surname>Paleari</surname><given-names>L</given-names></name>, <name><surname>Zerega</surname><given-names>B</given-names></name>, <name><surname>Postiglione</surname><given-names>MP</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5</article-title>. <source>Development</source>
<volume>126</volume>: <fpage>3795</fpage>&#x02013;<lpage>3809</lpage>. <?supplied-pmid 10433909?><pub-id pub-id-type="pmid">10433909</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Lo Iacono</surname><given-names>N</given-names></name>, <name><surname>Mantero</surname><given-names>S</given-names></name>, <name><surname>Chiarelli</surname><given-names>A</given-names></name>, <name><surname>Garcia</surname><given-names>E</given-names></name>, <name><surname>Mills</surname><given-names>AA</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects</article-title>. <source>Development</source>
<volume>135</volume>: <fpage>1377</fpage>&#x02013;<lpage>1388</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/dev.011759">10.1242/dev.011759</ext-link></comment>
<?supplied-pmid 18326838?><pub-id pub-id-type="pmid">18326838</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Robledo</surname><given-names>RF</given-names></name>, <name><surname>Rajan</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Lufkin</surname><given-names>T</given-names></name> (<year>2002</year>) <article-title>The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development</article-title>. <source>Genes Dev</source>
<volume>16</volume>: <fpage>1089</fpage>&#x02013;<lpage>1101</lpage>. <?supplied-pmid 12000792?><pub-id pub-id-type="pmid">12000792</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Bendall</surname><given-names>AJ</given-names></name>, <name><surname>Hu</surname><given-names>G</given-names></name>, <name><surname>Levi</surname><given-names>G</given-names></name>, <name><surname>Abate-Shen</surname><given-names>C</given-names></name> (<year>2003</year>) <article-title>Dlx5 regulates chondrocyte differentiation at multiple stages</article-title>. <source>Int J Dev Biol</source>
<volume>47</volume>: <fpage>335</fpage>&#x02013;<lpage>344</lpage>. <?supplied-pmid 12895028?><pub-id pub-id-type="pmid">12895028</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Chin</surname><given-names>HJ</given-names></name>, <name><surname>Fisher</surname><given-names>MC</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Ferrari</surname><given-names>D</given-names></name>, <name><surname>Wang</surname><given-names>CK</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Studies on the role of Dlx5 in regulation of chondrocyte differentiation during endochondral ossification in the developing mouse limb</article-title>. <source>Dev Growth Differ</source>
<volume>49</volume>: <fpage>515</fpage>&#x02013;<lpage>521</lpage>. <?supplied-pmid 17555518?><pub-id pub-id-type="pmid">17555518</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>H</given-names></name>, <name><surname>Bendall</surname><given-names>AJ</given-names></name> (<year>2009</year>) <article-title>Dlx5 Is a cell autonomous regulator of chondrocyte hypertrophy in mice and functionally substitutes for Dlx6 during endochondral ossification</article-title>. <source>PLoS One</source>
<volume>4</volume>: <fpage>e8097</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0008097">10.1371/journal.pone.0008097</ext-link></comment>
<?supplied-pmid 19956613?><pub-id pub-id-type="pmid">19956613</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Rasmussen</surname><given-names>MB</given-names></name>, <name><surname>Kreiborg</surname><given-names>S</given-names></name>, <name><surname>Jensen</surname><given-names>P</given-names></name>, <name><surname>Bak</surname><given-names>M</given-names></name>, <name><surname>Mang</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Phenotypic subregions within the split-hand/foot malformation 1 locus</article-title>. <source>Hum Genet</source>
<volume>135</volume>: <fpage>345</fpage>&#x02013;<lpage>357</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00439-016-1635-0">10.1007/s00439-016-1635-0</ext-link></comment>
<?supplied-pmid 26839112?><pub-id pub-id-type="pmid">26839112</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Sowinska-Seidler</surname><given-names>A</given-names></name>, <name><surname>Socha</surname><given-names>M</given-names></name>, <name><surname>Jamsheer</surname><given-names>A</given-names></name> (<year>2014</year>) <article-title>Split-hand/foot malformation&#x02014;molecular cause and implications in genetic counseling</article-title>. <source>J Appl Genet</source>
<volume>55</volume>: <fpage>105</fpage>&#x02013;<lpage>115</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s13353-013-0178-5">10.1007/s13353-013-0178-5</ext-link></comment>
<?supplied-pmid 24163146?><pub-id pub-id-type="pmid">24163146</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>van Silfhout</surname><given-names>AT</given-names></name>, <name><surname>van den Akker</surname><given-names>PC</given-names></name>, <name><surname>Dijkhuizen</surname><given-names>T</given-names></name>, <name><surname>Verheij</surname><given-names>JB</given-names></name>, <name><surname>Olderode-Berends</surname><given-names>MJ</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Split hand/foot malformation due to chromosome 7q aberrations(SHFM1): additional support for functional haploinsufficiency as the causative mechanism</article-title>. <source>Eur J Hum Genet</source>
<volume>17</volume>: <fpage>1432</fpage>&#x02013;<lpage>1438</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ejhg.2009.72">10.1038/ejhg.2009.72</ext-link></comment>
<?supplied-pmid 19401716?><pub-id pub-id-type="pmid">19401716</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Shamseldin</surname><given-names>HE</given-names></name>, <name><surname>Faden</surname><given-names>MA</given-names></name>, <name><surname>Alashram</surname><given-names>W</given-names></name>, <name><surname>Alkuraya</surname><given-names>FS</given-names></name> (<year>2012</year>) <article-title>Identification of a novel DLX5 mutation in a family with autosomal recessive split hand and foot malformation</article-title>. <source>J Med Genet</source>
<volume>49</volume>: <fpage>16</fpage>&#x02013;<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/jmedgenet-2011-100556">10.1136/jmedgenet-2011-100556</ext-link></comment>
<?supplied-pmid 22121204?><pub-id pub-id-type="pmid">22121204</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Xin</surname><given-names>Q</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Exome sequencing reveals a heterozygous DLX5 mutation in a Chinese family with autosomal-dominant split-hand/foot malformation</article-title>. <source>Eur J Hum Genet</source>
<volume>22</volume>: <fpage>1105</fpage>&#x02013;<lpage>1110</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ejhg.2014.7">10.1038/ejhg.2014.7</ext-link></comment>
<?supplied-pmid 24496061?><pub-id pub-id-type="pmid">24496061</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Sowinska-Seidler</surname><given-names>A</given-names></name>, <name><surname>Badura-Stronka</surname><given-names>M</given-names></name>, <name><surname>Latos-Bielenska</surname><given-names>A</given-names></name>, <name><surname>Stronka</surname><given-names>M</given-names></name>, <name><surname>Jamsheer</surname><given-names>A</given-names></name> (<year>2014</year>) <article-title>Heterozygous DLX5 nonsense mutation associated with isolated split-hand/foot malformation with reduced penetrance and variable expressivity in two unrelated families</article-title>. <source>Birth Defects Res A Clin Mol Teratol</source>
<volume>100</volume>: <fpage>764</fpage>&#x02013;<lpage>771</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/bdra.23298">10.1002/bdra.23298</ext-link></comment>
<?supplied-pmid 25196357?><pub-id pub-id-type="pmid">25196357</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Verzi</surname><given-names>MP</given-names></name>, <name><surname>Agarwal</surname><given-names>P</given-names></name>, <name><surname>Brown</surname><given-names>C</given-names></name>, <name><surname>McCulley</surname><given-names>DJ</given-names></name>, <name><surname>Schwarz</surname><given-names>JJ</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>The transcription factor MEF2C is required for craniofacial development</article-title>. <source>Dev Cell</source>
<volume>12</volume>: <fpage>645</fpage>&#x02013;<lpage>652</lpage>. <?supplied-pmid 17420000?><pub-id pub-id-type="pmid">17420000</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Birnbaum</surname><given-names>RY</given-names></name>, <name><surname>Everman</surname><given-names>DB</given-names></name>, <name><surname>Murphy</surname><given-names>KK</given-names></name>, <name><surname>Gurrieri</surname><given-names>F</given-names></name>, <name><surname>Schwartz</surname><given-names>CE</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Functional characterization of tissue-specific enhancers in the DLX5/6 locus</article-title>. <source>Hum Mol Genet</source>
<volume>21</volume>: <fpage>4930</fpage>&#x02013;<lpage>4938</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/hmg/dds336">10.1093/hmg/dds336</ext-link></comment>
<?supplied-pmid 22914741?><pub-id pub-id-type="pmid">22914741</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Feng</surname><given-names>J</given-names></name>, <name><surname>Bi</surname><given-names>C</given-names></name>, <name><surname>Clark</surname><given-names>BS</given-names></name>, <name><surname>Mady</surname><given-names>R</given-names></name>, <name><surname>Shah</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator</article-title>. <source>Genes Dev</source>
<volume>20</volume>: <fpage>1470</fpage>&#x02013;<lpage>1484</lpage>. <?supplied-pmid 16705037?><pub-id pub-id-type="pmid">16705037</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Ghanem</surname><given-names>N</given-names></name>, <name><surname>Jarinova</surname><given-names>O</given-names></name>, <name><surname>Amores</surname><given-names>A</given-names></name>, <name><surname>Long</surname><given-names>Q</given-names></name>, <name><surname>Hatch</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Regulatory roles of conserved intergenic domains in vertebrate Dlx bigene clusters</article-title>. <source>Genome Res</source>
<volume>13</volume>: <fpage>533</fpage>&#x02013;<lpage>543</lpage>. <?supplied-pmid 12670995?><pub-id pub-id-type="pmid">12670995</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Zerucha</surname><given-names>T</given-names></name>, <name><surname>Stuhmer</surname><given-names>T</given-names></name>, <name><surname>Hatch</surname><given-names>G</given-names></name>, <name><surname>Park</surname><given-names>BK</given-names></name>, <name><surname>Long</surname><given-names>Q</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>A highly conserved enhancer in the Dlx5/Dlx6 intergenic region is the site of cross-regulatory interactions between Dlx genes in the embryonic forebrain</article-title>. <source>J Neurosci</source>
<volume>20</volume>: <fpage>709</fpage>&#x02013;<lpage>721</lpage>. <?supplied-pmid 10632600?><pub-id pub-id-type="pmid">10632600</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Birnbaum</surname><given-names>RY</given-names></name>, <name><surname>Clowney</surname><given-names>EJ</given-names></name>, <name><surname>Agamy</surname><given-names>O</given-names></name>, <name><surname>Kim</surname><given-names>MJ</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Coding exons function as tissue-specific enhancers of nearby genes</article-title>. <source>Genome Res</source>
<volume>22</volume>: <fpage>1059</fpage>&#x02013;<lpage>1068</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/gr.133546.111">10.1101/gr.133546.111</ext-link></comment>
<?supplied-pmid 22442009?><pub-id pub-id-type="pmid">22442009</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Horike</surname><given-names>S</given-names></name>, <name><surname>Cai</surname><given-names>S</given-names></name>, <name><surname>Miyano</surname><given-names>M</given-names></name>, <name><surname>Cheng</surname><given-names>JF</given-names></name>, <name><surname>Kohwi-Shigematsu</surname><given-names>T</given-names></name> (<year>2005</year>) <article-title>Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome</article-title>. <source>Nat Genet</source>
<volume>37</volume>: <fpage>31</fpage>&#x02013;<lpage>40</lpage>. <?supplied-pmid 15608638?><pub-id pub-id-type="pmid">15608638</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Lilja</surname><given-names>T</given-names></name>, <name><surname>Wallenborg</surname><given-names>K</given-names></name>, <name><surname>Bjorkman</surname><given-names>K</given-names></name>, <name><surname>Albage</surname><given-names>M</given-names></name>, <name><surname>Eriksson</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients</article-title>. <source>Epigenetics</source>
<volume>8</volume>: <fpage>246</fpage>&#x02013;<lpage>251</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4161/epi.23752">10.4161/epi.23752</ext-link></comment>
<?supplied-pmid 23348913?><pub-id pub-id-type="pmid">23348913</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Wagner</surname><given-names>T</given-names></name>, <name><surname>Wirth</surname><given-names>J</given-names></name>, <name><surname>Meyer</surname><given-names>J</given-names></name>, <name><surname>Zabel</surname><given-names>B</given-names></name>, <name><surname>Held</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>1994</year>) <article-title>Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9</article-title>. <source>Cell</source>
<volume>79</volume>: <fpage>1111</fpage>&#x02013;<lpage>1120</lpage>. <?supplied-pmid 8001137?><pub-id pub-id-type="pmid">8001137</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Foster</surname><given-names>JW</given-names></name>, <name><surname>Dominguez-Steglich</surname><given-names>MA</given-names></name>, <name><surname>Guioli</surname><given-names>S</given-names></name>, <name><surname>Kwok</surname><given-names>C</given-names></name>, <name><surname>Weller</surname><given-names>PA</given-names></name>, <etal>et al</etal> (<year>1994</year>) <article-title>Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene</article-title>. <source>Nature</source>
<volume>372</volume>: <fpage>525</fpage>&#x02013;<lpage>530</lpage>. <?supplied-pmid 7990924?><pub-id pub-id-type="pmid">7990924</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Bell</surname><given-names>DM</given-names></name>, <name><surname>Leung</surname><given-names>KK</given-names></name>, <name><surname>Wheatley</surname><given-names>SC</given-names></name>, <name><surname>Ng</surname><given-names>LJ</given-names></name>, <name><surname>Zhou</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>SOX9 directly regulates the type-II collagen gene</article-title>. <source>Nat Genet</source>
<volume>16</volume>: <fpage>174</fpage>&#x02013;<lpage>178</lpage>. <?supplied-pmid 9171829?><pub-id pub-id-type="pmid">9171829</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Long</surname><given-names>F</given-names></name>, <name><surname>Ornitz</surname><given-names>DM</given-names></name> (<year>2013</year>) <article-title>Development of the endochondral skeleton</article-title>. <source>Cold Spring Harb Perspect Biol</source>
<volume>5</volume>: <fpage>a008334</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/cshperspect.a008334">10.1101/cshperspect.a008334</ext-link></comment>
<?supplied-pmid 23284041?><pub-id pub-id-type="pmid">23284041</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Maroteaux</surname><given-names>P</given-names></name>, <name><surname>Spranger</surname><given-names>J</given-names></name>, <name><surname>Opitz</surname><given-names>JM</given-names></name>, <name><surname>Kucera</surname><given-names>J</given-names></name>, <name><surname>Lowry</surname><given-names>RB</given-names></name>, <etal>et al</etal> (<year>1971</year>) [<article-title>The campomelic syndrome</article-title>]. <source>Presse Med</source>
<volume>79</volume>: <fpage>1157</fpage>&#x02013;<lpage>1162</lpage>. <?supplied-pmid 5555980?><pub-id pub-id-type="pmid">5555980</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Bi</surname><given-names>W</given-names></name>, <name><surname>Huang</surname><given-names>W</given-names></name>, <name><surname>Whitworth</surname><given-names>DJ</given-names></name>, <name><surname>Deng</surname><given-names>JM</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>98</volume>: <fpage>6698</fpage>&#x02013;<lpage>6703</lpage>. <?supplied-pmid 11371614?><pub-id pub-id-type="pmid">11371614</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Kozhemyakina</surname><given-names>E</given-names></name>, <name><surname>Lassar</surname><given-names>AB</given-names></name>, <name><surname>Zelzer</surname><given-names>E</given-names></name> (<year>2015</year>) <article-title>A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation</article-title>. <source>Development</source>
<volume>142</volume>: <fpage>817</fpage>&#x02013;<lpage>831</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/dev.105536">10.1242/dev.105536</ext-link></comment>
<?supplied-pmid 25715393?><pub-id pub-id-type="pmid">25715393</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Ferrari</surname><given-names>D</given-names></name>, <name><surname>Kosher</surname><given-names>RA</given-names></name> (<year>2002</year>) <article-title>Dlx5 is a positive regulator of chondrocyte differentiation during endochondral ossification</article-title>. <source>Dev Biol</source>
<volume>252</volume>: <fpage>257</fpage>&#x02013;<lpage>270</lpage>. <?supplied-pmid 12482714?><pub-id pub-id-type="pmid">12482714</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Hegele</surname><given-names>A</given-names></name>, <name><surname>Kamburov</surname><given-names>A</given-names></name>, <name><surname>Grossmann</surname><given-names>A</given-names></name>, <name><surname>Sourlis</surname><given-names>C</given-names></name>, <name><surname>Wowro</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Dynamic protein-protein interaction wiring of the human spliceosome</article-title>. <source>Mol Cell</source>
<volume>45</volume>: <fpage>567</fpage>&#x02013;<lpage>580</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.molcel.2011.12.034">10.1016/j.molcel.2011.12.034</ext-link></comment>
<?supplied-pmid 22365833?><pub-id pub-id-type="pmid">22365833</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Devotta</surname><given-names>A</given-names></name>, <name><surname>Juraver-Geslin</surname><given-names>H</given-names></name>, <name><surname>Gonzalez</surname><given-names>JA</given-names></name>, <name><surname>Hong</surname><given-names>CS</given-names></name>, <name><surname>Saint-Jeannet</surname><given-names>JP</given-names></name> (<year>2016</year>) <article-title>Sf3b4-depleted Xenopus embryos: A model to study the pathogenesis of craniofacial defects in Nager syndrome</article-title>. <source>Dev Biol</source>.</mixed-citation></ref><ref id="pgen.1006307.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Dixon</surname><given-names>J</given-names></name>, <name><surname>Jones</surname><given-names>NC</given-names></name>, <name><surname>Sandell</surname><given-names>LL</given-names></name>, <name><surname>Jayasinghe</surname><given-names>SM</given-names></name>, <name><surname>Crane</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>103</volume>: <fpage>13403</fpage>&#x02013;<lpage>13408</lpage>. <?supplied-pmid 16938878?><pub-id pub-id-type="pmid">16938878</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>A</given-names></name>, <name><surname>Schweitzer</surname><given-names>R</given-names></name>, <name><surname>Sun</surname><given-names>D</given-names></name>, <name><surname>Kaghad</surname><given-names>M</given-names></name>, <name><surname>Walker</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development</article-title>. <source>Nature</source>
<volume>398</volume>: <fpage>714</fpage>&#x02013;<lpage>718</lpage>. <?supplied-pmid 10227294?><pub-id pub-id-type="pmid">10227294</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Mills</surname><given-names>AA</given-names></name>, <name><surname>Zheng</surname><given-names>B</given-names></name>, <name><surname>Wang</surname><given-names>XJ</given-names></name>, <name><surname>Vogel</surname><given-names>H</given-names></name>, <name><surname>Roop</surname><given-names>DR</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>p63 is a p53 homologue required for limb and epidermal morphogenesis</article-title>. <source>Nature</source>
<volume>398</volume>: <fpage>708</fpage>&#x02013;<lpage>713</lpage>. <?supplied-pmid 10227293?><pub-id pub-id-type="pmid">10227293</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Ianakiev</surname><given-names>P</given-names></name>, <name><surname>Kilpatrick</surname><given-names>MW</given-names></name>, <name><surname>Toudjarska</surname><given-names>I</given-names></name>, <name><surname>Basel</surname><given-names>D</given-names></name>, <name><surname>Beighton</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27</article-title>. <source>Am J Hum Genet</source>
<volume>67</volume>: <fpage>59</fpage>&#x02013;<lpage>66</lpage>. <?supplied-pmid 10839977?><pub-id pub-id-type="pmid">10839977</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>Celli</surname><given-names>J</given-names></name>, <name><surname>Duijf</surname><given-names>P</given-names></name>, <name><surname>Hamel</surname><given-names>BC</given-names></name>, <name><surname>Bamshad</surname><given-names>M</given-names></name>, <name><surname>Kramer</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome</article-title>. <source>Cell</source>
<volume>99</volume>: <fpage>143</fpage>&#x02013;<lpage>153</lpage>. <?supplied-pmid 10535733?><pub-id pub-id-type="pmid">10535733</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Brunner</surname><given-names>HG</given-names></name>, <name><surname>Hamel</surname><given-names>BC</given-names></name>, <name><surname>Bokhoven</surname><given-names>Hv H</given-names></name> (<year>2002</year>) <article-title>P63 gene mutations and human developmental syndromes</article-title>. <source>Am J Med Genet</source>
<volume>112</volume>: <fpage>284</fpage>&#x02013;<lpage>290</lpage>. <?supplied-pmid 12357472?><pub-id pub-id-type="pmid">12357472</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>Y</given-names></name>, <name><surname>Abbassi</surname><given-names>S</given-names></name>, <name><surname>Li</surname><given-names>F</given-names></name>, <name><surname>Ding</surname><given-names>M</given-names></name>, <name><surname>Wu</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Distinct function of P63 isoforms during embryonic skeletal development</article-title>. <source>Gene</source>
<volume>519</volume>: <fpage>251</fpage>&#x02013;<lpage>259</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.gene.2013.02.021">10.1016/j.gene.2013.02.021</ext-link></comment>
<?supplied-pmid 23481305?><pub-id pub-id-type="pmid">23481305</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Nishanian</surname><given-names>TG</given-names></name>, <name><surname>Waldman</surname><given-names>T</given-names></name> (<year>2004</year>) <article-title>Interaction of the BMPR-IA tumor suppressor with a developmentally relevant splicing factor</article-title>. <source>Biochem Biophys Res Commun</source>
<volume>323</volume>: <fpage>91</fpage>&#x02013;<lpage>97</lpage>. <?supplied-pmid 15351706?><pub-id pub-id-type="pmid">15351706</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Watanabe</surname><given-names>H</given-names></name>, <name><surname>Shionyu</surname><given-names>M</given-names></name>, <name><surname>Kimura</surname><given-names>T</given-names></name>, <name><surname>Kimata</surname><given-names>K</given-names></name>, <name><surname>Watanabe</surname><given-names>H</given-names></name> (<year>2007</year>) <article-title>Splicing factor 3b subunit 4 binds BMPR-IA and inhibits osteochondral cell differentiation</article-title>. <source>J Biol Chem</source>
<volume>282</volume>: <fpage>20728</fpage>&#x02013;<lpage>20738</lpage>. <?supplied-pmid 17513295?><pub-id pub-id-type="pmid">17513295</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref073"><label>73</label><mixed-citation publication-type="journal"><name><surname>Rock</surname><given-names>MJ</given-names></name>, <name><surname>Holden</surname><given-names>P</given-names></name>, <name><surname>Horton</surname><given-names>WA</given-names></name>, <name><surname>Cohn</surname><given-names>DH</given-names></name> (<year>2010</year>) <article-title>Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and alphaVbeta3 integrin</article-title>. <source>Mol Cell Biochem</source>
<volume>338</volume>: <fpage>215</fpage>&#x02013;<lpage>224</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11010-009-0355-3">10.1007/s11010-009-0355-3</ext-link></comment>
<?supplied-pmid 20033473?><pub-id pub-id-type="pmid">20033473</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Livak</surname><given-names>KJ</given-names></name>, <name><surname>Schmittgen</surname><given-names>TD</given-names></name> (<year>2001</year>) <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title>. <source>Methods</source>
<volume>25</volume>: <fpage>402</fpage>&#x02013;<lpage>408</lpage>. <?supplied-pmid 11846609?><pub-id pub-id-type="pmid">11846609</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Trapnell</surname><given-names>C</given-names></name>, <name><surname>Pachter</surname><given-names>L</given-names></name>, <name><surname>Salzberg</surname><given-names>SL</given-names></name> (<year>2009</year>) <article-title>TopHat: discovering splice junctions with RNA-Seq</article-title>. <source>Bioinformatics</source>
<volume>25</volume>: <fpage>1105</fpage>&#x02013;<lpage>1111</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/btp120">10.1093/bioinformatics/btp120</ext-link></comment>
<?supplied-pmid 19289445?><pub-id pub-id-type="pmid">19289445</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Trapnell</surname><given-names>C</given-names></name>, <name><surname>Williams</surname><given-names>BA</given-names></name>, <name><surname>Pertea</surname><given-names>G</given-names></name>, <name><surname>Mortazavi</surname><given-names>A</given-names></name>, <name><surname>Kwan</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</article-title>. <source>Nat Biotechnol</source>
<volume>28</volume>: <fpage>511</fpage>&#x02013;<lpage>515</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nbt.1621">10.1038/nbt.1621</ext-link></comment>
<?supplied-pmid 20436464?><pub-id pub-id-type="pmid">20436464</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref077"><label>77</label><mixed-citation publication-type="journal"><name><surname>Huang da</surname><given-names>W</given-names></name>, <name><surname>Sherman</surname><given-names>BT</given-names></name>, <name><surname>Lempicki</surname><given-names>RA</given-names></name> (<year>2009</year>) <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat Protoc</source>
<volume>4</volume>: <fpage>44</fpage>&#x02013;<lpage>57</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nprot.2008.211">10.1038/nprot.2008.211</ext-link></comment>
<?supplied-pmid 19131956?><pub-id pub-id-type="pmid">19131956</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref078"><label>78</label><mixed-citation publication-type="journal"><name><surname>Bailey</surname><given-names>TL</given-names></name>, <name><surname>Machanick</surname><given-names>P</given-names></name> (<year>2012</year>) <article-title>Inferring direct DNA binding from ChIP-seq</article-title>. <source>Nucleic Acids Res</source>
<volume>40</volume>: <fpage>e128</fpage>
<?supplied-pmid 22610855?><pub-id pub-id-type="pmid">22610855</pub-id></mixed-citation></ref><ref id="pgen.1006307.ref079"><label>79</label><mixed-citation publication-type="journal"><name><surname>Kulakovskiy</surname><given-names>IV</given-names></name>, <name><surname>Vorontsov</surname><given-names>IE</given-names></name>, <name><surname>Yevshin</surname><given-names>IS</given-names></name>, <name><surname>Soboleva</surname><given-names>AV</given-names></name>, <name><surname>Kasianov</surname><given-names>AS</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>HOCOMOCO: expansion and enhancement of the collection of transcription factor binding sites models</article-title>. <source>Nucleic Acids Res</source>
<volume>44</volume>: <fpage>D116</fpage>&#x02013;<lpage>125</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkv1249">10.1093/nar/gkv1249</ext-link></comment>
<?supplied-pmid 26586801?><pub-id pub-id-type="pmid">26586801</pub-id></mixed-citation></ref></ref-list></back></article>